S ecci n e · Innovation · Policies

World Health Summit B ERLIN, GERMANY O CTOBER 15–17, 2017 VENUE

Kosmos www.facebook.com/worldhealthsummit Karl-Marx-Allee 131a www.linkedin.com/company/whs-foundation-gmbh 10243 Berlin www.twitter.com/WorldHealthSmt Germany Hashtag: #WHS2017

SAAL 10 ASIA

Poster SAAL 7 Exhibition Startup ELIZABETH Track BLACKWELL

Speaker Center SAAL 1 M8 SAAL 6 Foyer Lounge RUDOLF VIRCHOW EUROPE Press Area

Karl-Marx-Allee OUTDOOR ROBERT KOCH Meeting Point SAAL 5 OCEANIA

SAAL 2 SAAL 4 AMERICA AFRICA WORLD HEALTH SUMMIT BERLIN, GERMANY OC TOBER 15–17, 2017 SUNDAY | OCTOBER 15, 2017

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

PD 01 | Page 40 WS 01 | Page 42 WS 02 | Page 44 WS 03 | Page 46 WS 04 | Page 48 10:00’– Healthy and Gender Equality Improving Pandemic Tackling Barriers to European Initiatives 11:30 Resilient Cities within the Global Preparedness and Cancer Treatment for Health Research Joint United Nations Health Workforce Response and Care and Development Programme on HIV/AIDS ‹Alliance Charité – Universitäts- Access Accelerated European Commission ‹Alliance Monash University medizin Berlin Charité – Universitäts- Helmholtz Association Tehran University Women in Global Health Heidelberg Institute medizin Berlin of German Research of Medical Sciences of Public Health F. Ho—mann-La Roche Centers e.‹V. The Graduate Institute ‹Alliance Ltd. Scientific Panel of International and ‹Alliance for Health Development Studies WS 04a | Page 50 11:30’– Lunch Break (90 min) Long-term and 13:00 End-of-Life Care in Aging Societies Charité – Universitäts- medizin Berlin University of Coimbra Kyoto University ‹Alliance National Taiwan University University of Montreal PD 02 | Page 52 WS 05 | Page 54 WS 06 | Page 56 WS 07 | Page 58 WS 08 | Page 60 13:00’– Noncommunicable After the US COP21 Artificial Intelligence Defining an EU Global The Human Cell 14:30 Diseases Withdrawal in Health Health Strategy Atlas as a Basis for The NCD Alliance Centre Virchow-Villermé Fondation Botnar ‹Alliance Novel Therapies Sanofi for Public Health London School of Max Delbrück Center Paris-Berlin Hygiene and Tropical for Molecular Medicine German National Medicine Academy of Sciences Leopoldina e.‹V. ‹Alliance University of Geneva

Co—ee Break (30 min) PD 03 | Page 62 WS 09 | Page 64 WS 10 | Page 66 WS 11 | Page 68 WS 12 | Page 70 15:00’– Precision Medicine Migration and Global Cancer in Africa Access to Medicines New Approaches in 16:30 and Population Health Health Policy Charité – Universitäts- through Innovation Challenging Dementia Berlin Institute of Health Charité – Universitäts- medizin Berlin ‹Alliance Charité – Universitäts- Institut de Recherches medizin Berlin ‹Alliance The Graduate Institute medizin Berlin Cliniques de Montréal London School of Pfizer Inc of International and ‹Alliance ‹Alliance Hygiene & Tropical Development Studies World Dementia Max Delbrück Center for Medicine Council Molecular Medicin ‹Alliance World Stroke Sapienza University Organi zation KEY 01 | Page 72 17:00’– Opening Ceremony 18:30 Charité – Universitätsmedizin Berlin ‹Alliance

18:30’– Welcome Reception 21:30 MONDAY | OCTOBER 16, 2017

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

PD 04 | Page 76 WS 13 | Page 78 WS 14 | Page 80 WS 15 | Page 82 WS 16 | Page 84 09:00’– Big Data for Health Innovative New Ways New Structures for Diabetes, Meta - Global Health Security ’10:30 Governance in Fighting NTDs Translational Research bolism & Obesity Engagement in Conflict ‹Alliance German Network against German Centers for Charité – Universitäts- and Crisis Situations Monash University Neglected Tropical Health Research medizin Berlin Bundeswehr Command SAP SE Diseases Helmholtz Association ‹Alliance and Sta— College German Association of German Research Sanofi Center for Global Health of Research-based Centers e.‹V. Engagement Pharmaceutical Harvard Medical School Companies King’s College London

Co—ee Break (30 min) KEY 02 | Page 86 PD 04a | Page 88 11:00 – Health Policy in the The Beauty of Impact 12:30 G7/G20 Bayer Science & Johns Hopkins Education Foundation Bloomberg School of Public Health ‹Alliance

WS 16a | Page 90 12:30’– Lunch Break (90 min)¦ The Sustainable 14:00 World Health Summit Startup Track Pitch Competition Development Goals International Develop- ment Research Centre ‹Alliance The Graduate Institute of International and Development Studies KEY 03 | Page 92 PD 04b | Page 94 14:00 – Innovations Vaccination Apathy 16:00 in Digital Health London School of ‹Alliance Hygiene & Tropical SAP SE Medicine University of Coimbra ‹Alliance Pfizer Inc

Co—ee Break (30 min) PD 05 | Page 96 WS 17 | Page 98 WS 18 | Page 100 WS 19 | Page 102 WS 20 | Page 104 16:30 – Global Health Global Health Why must Patient Sepsis and Infections Promoting R&D 18:00 Security Financing Safety start in the in the 21st Century Capacity and Munich Security SEEK Development, Community? Leibniz Association Manufacturing Conference Strategic and European Resuscitation European and Develop- Pfizer Inc Organizational Council ing Countries Clinical Consultants GmbH German Resuscitation Trials Partnership Council Deutsche Gesellschaft ‹Alliance für Internationale National University Zusammenarbeit of Singapore World Health University Hospital Organization of Cologne

18:30 – World Health Summit Night | Page 106 23:00

Keynotes¦ Panel Discussions¦ Workshops TUESDAY | OCTOBER 17, 2017

SAAL 1 SAAL 6 SAAL 10 SAAL 2 SAAL 4 SAAL 5 RUDOLF VIRCHOW EUROPE ASIA AMERICA AFRICA OCEANIA

PD 06 | Page 110 WS 21 | Page 112 WS 22 | Page 114 WS 23 | Page 116 WS 24 | Page 118 09:00’– The Health Impact of One Health Equitable Access Ancient Cultures, Growing from ’10:30 War & Terror Max Planck Society to Universal Health Migrations and Health Response to International Committee Robert Koch Institute Coverage & Care Max Planck Society Preparedness of the Red Cross ‹Alliance Foundation ‹Alliance Tehran University for Innovative New University of Montreal of Medical Sciences Diagnostics The Graduate Institute of International and Development Studies

Co—ee Break (30 min) KEY 04 | Page 120 PD 06a | Page 122 11:00 – Vaccine Research Shaping the Future of 12:30 and Development Digital Healthcare in Coalition for Epidemic the Developing World Preparedness Deutsche Gesellschaft Innovations für Internationale London School of Zusammenarbeit Hygiene & Tropical Medicine ‹Alliance Max Planck Institute for Infection Biology WS 24a | Page 124 12:30’– Lunch Break (90 min)¦ Better Leadership: 14:00 KfW Hackathon “Hacking Global Health” Improved Health European School of Management and Technology InterAcademy Partnership for Health KEY 05 | Page 126 PD 06b | Page 128 14:00 – Governing the Future Access to Health 16:00 with the Sustainable F.‹Ho—mann-La Roche Ltd. Development Goals Merck ‹Alliance Novartis AG

Co—ee Break (30 min) PD 07 | Page 130 WS 25 | Page 132 WS 26 | Page 134 WS 27 | Page 136 WS 28 | Page 138 16:30 – Strengthening Making the Case Antimicrobial Healthy Exchange: Emerging Trends 18:00 Innovation and Health for Open Contracting Resistance Hospital Partnerships in Public Health Systems in Africa in Health International Federation for Global Health Education German Healthcare Transparency of Pharmaceutical European ESTHER Charité – Universitäts- Partnership International Manufacturers & Alliance medizin Berlin Joint United Nations Associations German Federal Ministry London School of Programme on HIV/AIDS for Economic Coopera- Hygiene & Tropical tion and Development Medicine Deutsche Gesellschaft ‹Alliance für Internationale Monash University Zusammenarbeit Tehran University of Medical Sciences Université Paris Descartes Université Sorbonne Paris Cité University of Geneva TABLE OF CONTENTS 7

Welcome Messages¦8 Key Facts¦16 Mission¦17 Topics 2017¦18 World Health Summit Presidents¦20 World Health Summit Scientific Committee¦21 World Health Summit Ambassadors and Council¦22 M8 Alliance¦24 World Health Summit Startup Track¦32 World Health Summit Night¦34 New Voices in Global Health¦36 Program, Sunday, October 15, 2017¦39 Program, Monday, October 16, 2017¦75 Program, Tuesday, October 17, 2017¦109 General Information¦141 Directions¦142 Accomodation¦144 Venue¦145 A–Z¦146 City of Berlin¦150 Speaker Index¦152 Supporting Institutions¦154 Partners¦156 Media Information¦161 Contacts¦162 Imprint¦166 WELCOME MESSAGES

8 WELCOME MESSAGE ANGELA MERKEL

Global challenges call for global That is why one of the goals of the 2030 Agenda responses. This applies also for Sustainable Development is to ensure uni- and in particular to the fight versal healthcare. This includes global responses against infectious diseases. These in the fight against antimicrobial resistance. All diseases do not end at national our e—orts to improve healthcare structures will borders. The global increase in amount to very little if therapies become ine—ec- mobility also increases risk that tive. Antibiotics must therefore be used respon- they will spread. The international sibly, so that the spread of resistant bacteria Angela Merkel community knows all too well can be limited. Moreover, new vaccines and anti- that epidemics can have disas- biotics must be developed. In tackling this great trous consequences. That is why, this year, Ger- challenge, it is paramount that we coordinate our many made Global Health Policy a focus of its support for research and development, and that G20 Presidency. Under the motto “Shaping an we employ our resources in a targeted way. I am interconnected world”, we and our partners have therefore delighted that the G20 countries have successfully sent a strong signal of cooperation. agreed to establish a global research initiative.

The aim is to strengthen the world’s healthcare Shaping an interconnected world: To fully live systems. This means guaranteeing both extensive up to this responsibility and give globalisation a preventive measures and, in the event of a crisis, human dimension, we must first have a com- a rapid international response. The United Nations prehensive dialogue. The World Health Summit and the World Health Organization are crucial has become a well and widely respected inter- for coordinating these e—orts. Their structures national forum when it comes to the joint search must be made fit for this purpose, and they must for e—ective responses to global health issues. receive su²cient funding. To e—ectively fight I want to express my heartfelt thanks for the global health crises, all actors need to cooperate valu able work you are doing, by contributing your e²ciently. A key requirement is of course that knowledge and experience to this common e—ort. countries have well functioning healthcare As patron of the World Health Summit 2017, I systems in place. It is not only important at local would like to welcome all the participants to Berlin. level, but also in the global interest, that health- care specialists on the ground can detect out- breaks of dangerous diseases at an early stage.

Angela Merkel Chancellor of the Federal Republic of Germany WELCOME MESSAGE EMMANUEL MACRON 9

In today’s connected and interdependent world, Personalized medicine and global health threats must be tackled globally. An inte- health must receive an integrated grated approach must be taken. This global ap- response, involving medicine, proach to health is one of the G20’s key priorities. biology, food, urbanization, environ - ment and education. To achieve The Sustainable Development Goals adopted as this, cooperation between states, part of the 2030 Agenda for Sustainable Develop- the scientific, economic and medi- ment of the United Nations are aimed at every cal stakeholders, and civil society country in the world in a global, partner-based is essential and must be planned Emmanuel Macron and universal approach. Goal 3 on Health, in par tic- over the long term. The World ular, aims to stamp out the epidemics of AIDS, Health Summit has become a key forum for address - tuberculosis, malaria and other communicable ing these issues in a cross-cutting manner by bringing diseases and to e—ectively fight noncommunica- together these actors on an international level. ble diseases by 2030. The objective is to ultimate- The terms of globality and universality ly provide universal health coverage, with access are now more than ever associated with health: to safe, e²cient, a—ordable vaccines and medi- • international preventive measures; cines. To make this happen, it is essential to support • quality care for all, accessible to all; the research and development of new vaccines. • renewed support for health as a driver of development, growth and stability; The resurgence in resistance to antibiotics, which • and an ambitious research policy, which is a source of progress. the World Health Organization, the G20 and the These are principles to which France is committed, European Union see as an absolute priority, has and which it supports in international bodies. proven that we must never stop being vigilant. To this end, France has joined forces with Germany As patron of this Summit, I would like to join with to create a global R&D platform on antibiotic the Chancellor of the Federal Republic of Germany resistance. This must be carried forward in an and the President of the European Commission in integrated, systemic and unified approach. We wishing you all an excellent and productive meeting. must link environmental, public and animal health at local, national and global levels based on the concept of “One Health”. France committed to this at the G20 in Hamburg and the Franco-German Council of Ministers in Paris. I want priority to be given to developing new medicines, but also to R&D for new methods of diagnosis. Emmanuel Macron President of the Republic of France 10 WELCOME MESSAGE JEAN-CLAUDE JUNCKER

As we get older, we naturally That shows the true importance of the World become more conscious of our Health Summit as a hub for expertise, innovation health. This year the European and cooperation. Here in Europe we are com- Union celebrated its 60th birth - mitted to leading the way. This year we brought day – a time both for celebration together networks of medical experts and hospi- and reflection on the health of tals in 26 countries to ensure that as many of the our Union. 30 million people in the EU su—ering from 8,000 rare diseases each year have access to the spe- The good news is that Europeans Jean-Claude Juncker cialised care and treatment they need. We also are living longer than ever before. sig nalled our strong and unequivocal com mitment Life expectancy has risen by a to promoting vaccination as a driving force for decade for both men and women in the last fifty improved health in Europe and the wider world. years. That is in large part thanks to the progress we have made in healthcare standards, invest - Our joint resolve to protect the health and well- ment in prevention and welfare and pioneering being of all of our citizens now and in the future research enabling breakthroughs in the fight is stronger than ever. As with every year, the against disease and illness. World Health Summit is a key milestone in our e—orts. I urge you all to make the most of the However, as this year’s World Health Summit week and wish you successful event full of healthy themes show, there is no room for complacency discussions. when it comes to tackling the new and urgent health challenges facing Europe and the rest of the world. Poverty, rising inequalities and migra- tion flows are all issues which have a significant impact on global health. Ensuring that as many Jean-Claude Juncker citizens of the world have access to healthcare President of the European Commission is a responsibility for us all. The same goes for research into prevention, sustainable develop- ment and understanding the health impact of an older and more urban population.

12 WELCOME MESSAGE WORLD HEALTH SUMMIT PRESIDENTS

Dear Friends and Colleagues, neurodegenerative conditions remain the leading causes of death worldwide. The year 2017 has been another amazing Epidemics are turning into pandemics year packed with scientific progress. through the increasing interconnectivity Genome editing of immune cells is making of our world and the globalization of gene therapy of cancer a reality. A con- lifestyles. All the while, millions of people tinued digital revolution is providing a are fleeing war, terror, natural disasters, massive accumulation of new data related and poverty. It is growing harder to to health and disease. Great advances achieve and maintain e—ective healthcare toward personalized and precision medi- in rural areas and spreading megacities. Hélène Boisjoly cine and a plethora of applications are What can we do? arising from new methods in cell biology and medical technology. Those are just “Give me but a firm spot on which to a few of the central topics at the World stand, and I shall move the earth,” said the Health Summit in 2017. But unfortunately, great Greek mathematician Archimedes. despite these great achievements – and What sort of spot would be required to their parallels in the acceleration of the improve global health? This firm spot can innovation cycle for medical technologies only be the reliable international coopera- and equipment – the global burden of tion of all stakeholders – from academics disease has remained largely unchanged. to politicians, from the private sector and civil society. A milestone in this quest Detlev Ganten We should be able to translate all this was the prominent position health topics progress in science into better standards assumed on the agendas of this year’s G7 of health for all, but too many obstacles and G20 meetings. But we cannot leave remain. Noncommunicable diseases such things there; it is our shared responsibility as hypertension, cancer, diabetes, and to turn discussions into action. WELCOME MESSAGE WORLD HEALTH SUMMIT PRESIDENTS 13

The World Health Summit 2017 brings As presidents of the World Health Summit together stakeholders and decision- 2017, we cordially invite you to make makers from all sectors, and from all over the best of this unique event, which will the world. Our combined forces can feature over 40 sessions, more than achieve change, and provide the firm 200 expert speakers and 2,000 partici- spot from which to improve health world- pants from 100 countries. Join us to make wide. The World Health Summit Regional this world a healthier world. Meeting held last May in the Canadian city of Montreal demonstrated what can We look forward to welcoming you at the be achieved if we unite the brightest World Health Summit 2017 in Berlin! minds in health. The World Health Summit in Berlin will carry this momentum for- ward to contribute to an agenda by which health can be improved globally.

Helène Boisjoly Detlev Ganten

World Health Summit World Health Summit President 2017 Founding President University of Montreal Charité – Universitäts- Canada medizin Berlin 14 TESTIMONIALS CHARITÉ, BIH, MDC

Karl Max Einhäupl Axel Radlach Pries Astrid Lurati

“We need to strive towards the “Forums such as the World Health “The healthcare industry is increas- highest possible level of healthcare Summit are essential if we are to ingly faced with an ever growing in order to best help our patients keep up with the pace of new trends demand for cost intensive, high-tech and all those in need of medical and possibilities that have emerged solutions for unmet medical needs. treatment. Simultaneously, we must concerning life-long medical educa- Simultaneously, resources remain develop superb preventive strate- tion. For many years now, the World limited and tight budgets must be gies to ensure that the world’s Health Summit’s agenda has prior- met. The World Health Summit population remains healthy in the itized the education of tomorrow’s unites international medical aca- first place. The World Health Summit healthcare workforce. The summit demics, healthcare experts and key brings together experts from across has thus emerged as a leading voice political protagonists within a con - the globe to improve both health- in this matter, reaching students and text of information exchange, open care and prevention. We are thus institutions across the globe.” discussion and resourceful network- extremely excited to welcome such ing. It thus serves as an excellent an array of excellent minds to Berlin forum for developing constructive, and to the Charité for the annual sustainable and prompt answers to summit in October.” this contemporary global challenge.”

Karl Max Einhäupl Axel Radlach Pries Astrid Lurati Chief Executive O²cer Dean Hospital Director Charité – Universitätsmedizin Berlin Charité – Universitätsmedizin Berlin Charité – Universitätsmedizin Berlin TESTIMONIALS CHARITÉ, BIH, MDC 15

Ulrich Frei Rolf Zettl Martin Lohse

“The world of healthcare is changing “The Berlin Institute of Health aims “The Max Delbrück Center for rapidly and we need to rethink our to create an innovative translational Molecular Medicine and the Berlin approaches on all levels. First and research commons of Charité and Institute of Health are both commit- foremost we should work towards a Max Delbrück Center, enhancing ted to translating groundbreaking system that focuses on the medical personalized medicine and advanced research results into clinical appli- outcomes of our patients. We face therapies research in Germany and cations. By achieving this we can an unprecedented opportunity in for the global population at large. contribute to improving peoples’ the form of vast amounts of medical Pursuing this agenda, the World health and quality of life. Coopera- data. We need forums like the World Health Summit is an excellent plat- tion and exchange among the Health Summit in order to connect form to exchange and enhance involved players is an important to global experts and thus channel experience and research findings.” element in achieving world-class the potential of this data.” translational research. For this, the World Health Summit is the ideal forum to present our results and ideas and discuss them with leading health experts.”

Ulrich Frei Rolf Zettl Martin Lohse Medical Director Chief Executive O²cer Scientific Director, Max Delbrück Center for Charité – Universitätsmedizin Berlin Berlin Institute of Health Molecular Medicine, and Spokesperson of the Executive Board, Berlin Institute of Health 16 KEY FACTS

The World Health Summit is one of the world’s most prominent strategic forums for global health. The interdisciplinary event takes place within an atmosphere of academic freedom and is the premiere international platform for exploring strategic developments and decisions in the area of healthcare.

Facts at a glance Social Media • Annual event in Berlin www.facebook.com/worldhealthsummit • Patronage: German Chancellor Angela Merkel, www.twitter.com/WorldHealthSmt President of the Republic of France Emmanuel www.linkedin.com/company/whs-foundation-gmbh Macron and European Commission President Hashtag: #WHS2017 Jean-Claude Juncker • Mission: improve healthcare all over the world • Participants: 2,000 from 100 countries • Founded: 2009 on the 300th anniversary of the founding of the Charité Hospital Academia • Organized by the WHS Foundation GmbH, a subsidiary of Charité – Universitätsmedizin Berlin

Participants • Top-level researchers and members WORLD of the scientific community Private Civil Sector HEALTH Society • High-profile political decision-makers • Executives and representatives from the SUMMIT healthcare system • Leaders of the health-related industry and technology sector • Representatives of civil society and foundations Policy • Students and young professionals from Makers all health-related fields MISSION 17

VISION AND GOALS MAIN GOALS AND PARTNERSHIP ASSETS

The World Health Summit is the annual confer- The M8 Alliance is improving global health ence of the M8 Alliance of Academic Health through pursuit of five strategic goals: Centers, Universities and National Academies. Through the InterAcademy Partnership (IAP) • Bring together all stakeholders at the for Health, it is organized in collaboration with level of equals national academies of science in 97 countries. • Establish a unique and sustainable The World Health Summit aims to improve health high-level forum and network all over the planet, catalyzing that process through collaboration and open dialogue, and • Help define the future of medicine, steering tomorrow’s agenda to improve research, research and healthcare education, healthcare, and policy outcomes. • Find answers to major health challenges – It brings together researchers, physicians, key both today and tomorrow government o²cials, and representatives from industry as well as from NGOs and healthcare • Make global recommendations and systems all over the world to address the most set health agendas worldwide pressing issues facing every facet of healthcare and medicine in the upcoming decade and beyond.

The World Health Summit is built on the stable foundation of academic excellence provided by the M8 Alliance and has strong political support from a variety of partners at global, national and state levels. 18 TOPICS 2017

Health Policy in the G7/G20: Vaccine Research and Development: The Future of Global Health Governance Challenges and Opportunities Healthcare has developed into a key policy issue that When it comes to fighting infectious diseases, vaccines is discussed at both national and international levels. o—er top economic and social value. Intensified global In 2017, the G20 will for the first time include a meeting e—orts to step up vaccine research and development of national Health Ministers in a forum set to cover are therefore a must, especially for neglected tropical topics like health security and Antimicrobial Resistance. diseases. A central challenge is that in some developed The health governance issues inherent in the Sustain- countries, where popular perceptions no longer view able Development Goals have underlined how increas- infection or epidemics as a serious risk, mindsets will ing financial and political commitments are central need to change. to solving global health challenges. Strengthening Innovation and Health Systems in Africa Global Health Security: Achieving the Sustainable Development Goals will Policy Responses to Planetary Challenges require significant innovations regarding investments If we want to create a world that is more secure from and partner ships with Africa. Attaining these goals will infectious diseases and other threats to health, the only be possible via utilizing integrated approaches to global community must enhance its collective capa - health, development and security, as well as consensus- city for resilience, and respond more quickly to crises. building based upon knowledge exchange. Tools and To reach those goals, we must first create and nurture approaches used for goals such as ending the AIDS policy synergies between nation-states and inter - epidemic in Africa could be used for a process of social national organizations, and then move towards transformation which will contribute to achieving other im proving communication activities with both public SDGs without leaving anyone behind. and private stakeholders. Big Data for Health Governance: Healthy and Resilient Cities: Benefits, Frameworks and Ethics Rethinking Urban Transformation Data is now a cornerstone of the healthcare industry. Urban populations face many health risks, among It documents everything from blood pressure readings them pollution, noise, overcrowding, tra²c, insu²cient and surgical records to insurance claims, immunization access to drinking water and sanitary facilities, crime, histories, patient demographics and receipts of payment. and infectious disease. A major challenge is integrating But even though Big Data can bridge the gap between health into urban planning, investment and policy healthcare delivery and population health and improve decisions – and making it a transformative driver of many health outcomes through enhanced methods of sustainable development at the city level. research, the detailed collection of personal information poses ethical, regulatory and technical challenges. 19 20 WORLD HEALTH SUMMIT PRESIDENTS

PRESIDENTS 2017 FORMER PRESIDENTS

HÉLÈNE BOISJOLY DETLEV GANTEN 2016 2015 2014 Dean Honorary Chairman ANTOINE FLAHAULT SHUNICHI FUKUHARA JOSÉ OTÁVIO AULER JR. Faculty of Medicine, of the Board, Director Dean Dean University of Montreal, Charité Foundation, Institute of Global Health, School of Public Health, Faculty of Medicine, Canada Germany University of Geneva, Kyoto University, University of São Paulo, Switzerland Japan Brazil

2013 2012 2011 JOHN EU-LI WONG MICHAEL J. KLAG STEVE WESSELINGH Chief Executive O²cer Former Dean Dean National University Johns Hopkins Bloomberg Monash University, Health System, School of Public Health, Melbourne, Singapore USA Australia

2010 2009 STEVEN K. SMITH AXEL KAHN Pro Rector, Health Dean Imperial College London, Sorbonne Paris Cité, United Kingdom France WORLD HEALTH SUMMIT SCIENTIFIC COMMITTEE 21

CO-CHAIRS MEMBERS

HÉLÈNE BOISJOLY STEFAN KAUFMANN RIFAT ATUN DAVID DE KRETSER BÄRBEL-MARIA KURTH Dean Director Director, Global Health Professor, Director, Faculty of Medicine, Max Planck Institute Systems Cluster Reproductive Epidemiology and University of Montreal, for Infection Biology, Harvard T.H. Chan Endocrinology Health Monitoring Canada Germany School of Public Health, Monash University, Robert Koch Institute, USA Australia Germany The World Health Summit Scientific Committee consists of the M8 Alliance Executive Committee (see page 27) and these members of the World Health Summit Council:

KLAUS LINDPAINTNER EDUARDO PISANI ERICH R. REINHARDT Scientific Director Former Executive Director Chair of the Board King Abdullah International International Federation Medical Valley Medical Research Center, of Pharmaceutical EMN e.‹V., Al Ahsa-Jeddah-Riyadh, Manufacturers & Asso- Germany Saudi Arabia ciations, Switzerland

HEINZ RIEDERER GÜNTER STOCK Managing Director President iNG innovation. ALLEA Nachhaltigkeit. All European Academies, Gesundheit, Germany Germany 22 WORLD HEALTH SUMMIT AMBASSADORS AND COUNCIL

COUNCIL

WORLD HEALTH SUMMIT AMBASSADORS CHAIR MEMBERS

ALA ALWAN University of Washington, Department of Global Health

RIFAT ATUN Harvard T.H. Chan School of Public Health

TILL BÄRNIGHAUSEN MANFRED DIETEL ECKART VON MICHAEL RABBOW ILONA KICKBUSCH Heidelberg University Director, Comprehensive HIRSCHHAUSEN Senior Advisor The Graduate Institute Cancer Center Medical Doctor E&P Focus Africa of International and INGO BEHNEL Charité – Universitäts- and Cabaret Consulting, Development Studies, German Federal Ministry medizin Berlin, Germany Germany Germany Switzerland of Health

CHRISTOPH BEIER Deutsche Gesellschaft für Internationale Zusammenarbeit

CHRISTOPH BENN The Global Fund to Fight AIDS, Tuberculosis and Malaria HEINZ RIEDERER REINHARD SCHÄFERS ANSGAR TIETMEYER Managing Director Former Ambassador Former Head of TOBIAS BERGNER iNG innovation. Federal Republic Public A—airs German Federal Foreign Nachhaltigkeit. of Germany Deutsche Bank AG, O²ce Gesundheit, Germany Germany ARNAUD BERNAERT World Economic Forum

CATHERINA BÖHME Foundation for Innovative New Diagnostics

CHARLES YANKAH Chairman of the Board Afrika Kulturinstitut e.‹V., Berlin, Germany WORLD HEALTH SUMMIT COUNCIL 23

MEMBERS

THOMAS B. CUENI ZSUZSANNA JAKAB PHILIPPE MEYER MATHIAS SCHELLER Int. Federation of World Health Organization Descartes University Albertinen-Diakoniewerk Pharmaceutical Manufacturers‹‹& Associations ASHISH JHA JÜRGEN MLYNEK HANS J. SCHELLNHUBER Harvard Global Health Falling Walls Foundation Potsdam Institute for MANFRED DIETEL Institute Climate Impact Research Charité – Universitäts- MATSHIDISO REBECCA medizin Berlin STEFAN KAUFMANN MOETI* GEORG SCHÜTTE Max Planck Institute World Health Organization German Federal Ministry KLAUS DUGI for Infection Biology of Education and Research Ferring Pharmaceuticals BERND MONTAG SUSANNA KRÜGER Siemens Healthineers GÜNTER STOCK TIMOTHY EVANS Save the Children ALLEA All European Academies World Bank Germany ANDREAS PENK Pfizer Germany LOTHAR WIELER ROLAND GÖHDE BÄRBEL KURTH Robert Koch Institute German Healthcare Robert Koch Institute HAGEN PFUNDNER Partnership Roche Pharma AG (* to be confirmed) STEVE LANDRY JÖRG HACKER Bill & Melinda Gates PETER PIOT German National Academy of Foundation London School of Hygiene Sciences Leopoldina e.‹V. and Tropical Medicine YVES LEVY ANDREW HAINES Institut national de la santé ERICH REINHARDT London School of Hygiene & et de la recherche médicale Medical Valley Tropical Medicine MARION LIESER HEINZ RIEDERER MARGARET HAMBURG* Oxfam Germany iNG innovation. American Association Nachhaltigkeit. Gesundheit, for the Advancement KLAUS LINDPAINTNER of Science King Abdullah International MAIKE RÖTTGER Medical Research Center Association Development INGRID-GABRIELA HOVEN* and Humanitarian Aid German Federal Ministry LUIZ LOURES of Economic Cooperation UNAIDS and Development 24 M8 ALLIANCE

MISSION

The M8 Alliance’s vision is to harness academic built. It functions as a permanent platform for framing excellence to improve global health. the future considerations of global medical develop- ments and health challenges in an equitable fashion. The M8 Alliance of Academic Health Centres, Universi- ties and National Academies is a collabo ration between The M8 Alliance promotes both “bench-to-bedside” academic institutions committed to improving global translation of research and the transfor mation of cur- health. Working together with political and economic rent medical care approaches to treating the ill. It is decision-makers, its primary goal is to develop science- seeking to accomplish this through the creation of a based solutions to health challenges all over the world. healthcare system focused on the e—ective prevention of diseases, as well as the adaptation of health-related This international network is the outstanding academic solutions to rapidly changing living conditions through foundation upon which the World Health Summit – the research in priority areas like shifting demo graphics, pre-eminent annual forum for healthcare dialogue – is urbanization and climate. M8 ALLIANCE 25

Tehran University of Medical Sciences

Tehran University of Medical Sciences (TUMS) is accredited with premier status by the Accreditation Service for International Colleges (ASIC). ASIC is recognized by the United Kingdom Department for Education and Skills (DfES), the United Kingdom Department for Universities, Innovation and Skills (DUIS), the United Kingdom Border and Immigration Agency (Home Office), the United Kingdom Office for Standards in Education (Ofsted). ASIC is a member of Council for Higher Education Accreditation (CHEA). 26 M8 ALLIANCE MEMBER INSTITUTIONS

GOALS

The M8 Alliance is improving global health through • Setting an agenda for global health improvement pursuit of five strategic goals: by addressing issues of interest to academic health science centers, and conveying findings and recom- • Developing a worldwide network of academic health mendations based on scientific evidence through science centers, and bringing together universities the generation of key statements; and healthcare providers; • Positioning the M8 Alliance as an authoritative, • Facilitating dialogue through the World Health Summit credible and respected influence when it comes to across a global network of stake holders who are decision-making in global health; and engaged with academic health science centers. These stakeholders include (among others) individuals and • Creating a knowledge base amongst M8 Alliance institutions active in government, industry and com- members, which directly involves the promo tion of merce, inter-governmental agencies, healthcare mutual learning, research collaboration, the enrich- pro viders, academies of medicine and science, pro- ment of educational capabilities and enhanced fessional associations and the media; clinical outcomes. M8 ALLIANCE LEADERSHIP 27

EXECUTIVE COMMITTEE

HÉLÈNE BOISJOLY DETLEV GANTEN JOÃO GABRIEL SILVA ANTOINE FLAHAULT Acting International Founding President Incoming International Past International President Honorary Chairman President President Dean, Faculty of of the Board, Rector, University of Coimbra, Director, Institute Medicine, University Charité Foundation, Portugal of Global Health, of Montreal, Germany University of Geneva, Canada Switzerland

AXEL RADLACH PRIES MICHAEL J. KLAG BEN CANNY JOSÉ OTÁVIO AULER JR. Dean of Host Institution Strategic Co-operation Governance and O´cer at large Charité – Universitäts medizin and Stakeholder Liaison Fundraising Dean, Faculty of Medicine, Berlin, Former Dean, Johns Hopkins Head, School of Medicine, University of São Paulo, Germany Bloomberg School of Public University of Tasmania, Brazil Health, Baltimore, Australia United States of America 28 M8 ALLIANCE LEADERSHIP

M8 ALLIANCE HEADS OF DELEGATION

Australia France Italy

CHRISTINA MITCHELL GÉRARD FRIEDLANDER LUCIANO SASO Dean Dean Vice-Rector for European Monash University, Melbourne Faculty of Medicine, University University Networks of Paris Descartes Sapienza University

Brazil FRANÇOIS HOULLIER Acting President Japan JOSÉ OTÁVIO AULER JR. Université Sorbonne Paris Cité Dean SHUNICHI FUKUHARA Dean, Faculty of Medicine, Dean University of São Paulo Germany School of Public Health, Kyoto University EDUARDO KRIEGER KARL MAX EINHÄUPL Former President Chief Executive O²cer Brazilian Academy of Sciences Charité – Universitätsmedizin Berlin Portugal

AXEL RADLACH PRIES FERNANDO REGATEIRO Canada Dean Chairman of the Board of Directors Charité – Universitätsmedizin Berlin Coimbra University Hospitals HÉLÈNE BOISJOLY Dean JOÃO GABRIEL SILVA Faculty of Medicine, Iran Rector University of Montreal University of Coimbra ALI JAFARIAN TARIK MÖRÖY Chancellor President Tehran University of Medical Sciences Russian Federation Clinical Research Institute Montreal (IRCM) AMIRHOSSEIN TAKIAN IVAN DEDOV Chair and Professor President Global Health and Public Policy, Russian Academy China Ministry of Health and Medical of Medical Sciences Education XUETAO CAO EVGENY SIDORENKO President Vice-President Chinese Academy of Medical Sciences‹‹& Russian Academy Peking Union Medical College of Medical Sciences

DEPEI LIU Co-Chair InterAcademy Partnership (IAP) for Health M8 ALLIANCE LEADERSHIP 29

Singapore Taiwan USA

JOHN EU-LI WONG CHANG-CHUAN CHAN ELLEN MACKENZIE Chief Executive O²cer Associate Dean Dean National University Health System National Taiwan University Johns Hopkins Bloomberg Senior Vice-President (Health A—airs), School of Public Health, National University of Singapore Baltimore Turkey KHAY GUAN YEOH MICHAEL J. KLAG Dean MAHMUT AK Former Dean Yong Loo Lin School of Medicine, Rector Johns Hopkins Bloomberg National University of Singapore Istanbul University School of Public Health, Baltimore BAHAÜDDIN ÇOLAKOGLU Switzerland Dean Istanbul University, International HENRI BOUNAMEAUX Faculty of Medicine Dean LEONEL VALDIVIA Faculty of Medicine, President University of Geneva Uganda World Federation of Academic Institutions for Global Health ANTOINE FLAHAULT NELSON K. SEWANKAMBO Director Principal STEVEN A. WARTMAN Institute of Global Health Makerere University President & Chief Executive O²cer Association of Academic Health ILONA KICKBUSCH Centers Director United Kingdom Global Health Program, Graduate Institute PETER PIOT Individual Members Director BERTRAND LEVRAT London School of Hygiene & RIFAT ATUN Chief Executive O²cer Tropical Medicine Director Geneva University Hospitals Global Health Systems Cluster, ELIO RIBOLI Harvard T.H. Chan School CLAUDINE MATHIEU-THIÉBAUD Director of Public Health, USA Director School of Public Health, National and Inter national A—airs, Imperial College London BEN CANNY Geneva University Hospitals Head School of Medicine, University of Tasmania, Australia 30 31

WELCOME TO THE WORLD HEALTH SUMMIT BERLIN 2017 32 WORLD HEALTH SUMMIT STARTUP TRACK

Held under the Pitch high patronage of: Monday, October 16, 12:45 Hermann Gröhe Saal 1 | Rudolf Virchow Federal Minister of Health Award Germany Monday, October 16, 18:30 The World Health Summit Startup Saal 1 | Rudolf Virchow Track highlights outstanding ideas and innovative business concepts The winner will be awarded by that have the potential to revolu- Minister of Health Hermann Gröhe. tionize healthcare and improve Jury global health. KAI-UWE BINDSEIL 70 applications from 23 countries were assessed by Berlin Partner for Business and Technology the jury to select the 25 shortlisted organizations, JUTTA KLAUER which were subsequently invited to the World Pfizer Germany Health Summit 2017. Of these, 10 finalists will pitch SHARI LANGEMAK their ideas in front of the audience and jury on Philips Monday, October 16. MARKUS MÜSCHENICH The winner will be awarded by German Federal Flying Health Minister of Health Hermann Gröhe at the World ANNE KJAER RIECHERT Health Summit Night. ReDI School of Digital Integration RENATE RADON Microsoft Germany Benefits OLIVER SCHENK • Awarded by the German Minister of Health German Ministry of Health • Special access to the World Health Summit and UTE E. WEILAND M8 Alliance network Deutschland – Land der Ideen • Exclusive coaching from FLYING HEALTH, one of the leading company builders for health startups in Germany WORLD HEALTH SUMMIT STARTUP TRACK 33

THE 10 FINALISTS

AMBOSS | Germany imito AG | Switzerland Business Area: Education Business Area: Visual Documentation www.amboss.com www.imito.io

Amparo GmbH | Germany monikit UG | Germany Business Area: Assistive Devices Business Area: Epilepsy www.amparo.world www.monikit.com

CareNX Innovations | India PharmaChk | USA Business Area: Maternal and Child Health Business Area: Quality Detection www.carenx.com doctHERs | Pakistan SciDogma Research | India Business Area: Digital Health Business Area: Diagnostics www.docthers.com

Fosanis GmbH | Germany WeCare.id | Indonesia Business Area: Cancer Care Business Area: Healthcare Financing www.fosanis.de www.wecare.id

www.worldhealthsummit.org/whs-2017/startup-track 34 WORLD HEALTH SUMMIT NIGHT

Monday, October 16, 18:30 The World Health Summit Night as the central networking event Saal 1 | Rudolf Virchow hosts the award ceremony of the Startup Track.

36 NEW VOICES IN GLOBAL HEALTH

October 15–17, 2017, 09:00–18:00 In front of Saal 7 | Elizabeth Blackwell The selected New Voices in Global Health are:

The New Voices in Global Health initiative Kiarash Shirbandi pro motes the active participation of young Ahvaz Jundishapur University scientists in the World Health Summit. of Medical Sciences, Iran It is supported by the M8 Alliance of Academic “Global View of HIV Prevalence in Prisons: Health Centers, Universities and National A Systematic Review and Meta-Analysis” Academies. It is aimed at empowering research, policy and advocacy initiatives among future Luz Upegui leaders in global health, who are invited to send RWTH Aachen University, Germany in abstracts of their scientific work and ideas. “Antimicrobial Resistance: Knowledge Towards Antibiotics in a Mexican Population” The World Health Summit Scientific Committee (see page 21) identified the best applications Anne Musuva based on international academic standards. Population Services Kenya The selected candidates will be able to display “The Kenyan Malaria Market after the A—ordable their work in a special poster exhibition, Medicines Facility for Malaria” thus playing an active role in the World Health Summit. Shubha Nagesh Latika Roy Foundation, India “Community Health Workers in Early Intervention for Children with Special Needs in the Uttarakhand Himalayas” NEW VOICES IN GLOBAL HEALTH 37

Faith Nawagi M Tasdik Hasan Global Educational Exchanges in International Center for Diarrheal the Medicines and the Health Professions, Diseases Research, Bangladesh a service of ECFMG, Uganda “Exploring Mental Health Services Among “Regional Networks: An Approach to Enhance Climate Victims in a Cyclone A—ected Area Global Health Exposure for Medical and Health of Coastal Bangladesh” Professional Students in Africa” Surendra Karki Nakazinga Ndugwa UNSW, Australia University of Queensland, Australia “Association Between Body Mass Index and “Exploring the Health Systems Requirements Laboratory-confirmed Influenza in Middle-aged for Scaling up Care for Psychosocial Early and Older Adults: A Prospective Cohort Study” Childhood Development in Uganda” Solomon Abiola Derick Niyonshima University of Rochester Medical Center, USA Makerere University, Uganda “Real-Time Geospatial Forecasting of Infectious “Determination of Staphylococcus Aureus Diseases Using mHealth app ‘Node’, Lagos, Contamination of Liquid Local Herbal Medicine Nigeria 2015 Ebola Case Study” Sold in Kampala City, Uganda”

Prramog , Sunday, October 15, 2017

Program

SUNDAY, OCTOBER 15 40 SUNDAY, OCTOBER 15

PANEL DISCUSSION

PD 01 HEA LT H Y AND RESILIENT CITIES Rethinking Urban Transformation SAAL 6 | EUROPE 10:00 – 11:30

HOSTS

Joint United Nations Programme on HIV/AIDS (UNAIDS)

M8 Alliance: Tehran University of Medical Sciences

M8 Alliance: The Graduate Institute of International and Development Studies

Two transformative agendas come responding to chronic stresses and acute together at the city level – the new urban shocks. A central question is how we agenda and implementation of the can best achieve urban resilience, so that sustainable development goals. Many individuals, communities, institutions, global health actors have recognized that businesses, and systems within a city are cities play an increasingly important role motivated to survive, adapt, and grow. in ensuring health and well-being and PROGRAM 41

CHAIR 15

Ilona Kickbusch , SUN The Graduate Institute of International and Development Studies | Global Health Center | Director | Switzerland GRAM O Anna Matshidiso Rebecca Dworakowska Moeti PR

SPEAKERS

Anna Dworakowska Mohammed Adjei Sowah Polish Smog Alert | Co-Founder | Poland Mayor of Accra | Ghana What Di¼erence can Innovative What Role can Mayors Play in Citizen Action on Urban Health Make Initiating Action on NCDs

Ali Jafarian José Zuniga Ali Mohammed Adjei Tehran University of Medical Sciences | Joint United Nations Programme Jafarian Sowah Chancellor | Iran on HIV/AIDS (UNAIDS) | The Universities Role in Addressing Special Adviser on Fast-Track Cities | Urbanization and Noncommunicable Switzerland Risk Factors Fast Track Cities in Ending the AIDS Epidemic Matshidiso Rebecca Moeti World Health Organization (WHO) | WHO Regional O²ce for Africa | Ilona José Regional Director for Africa | Congo Kickbusch Zuniga How can the WHO Support Cities in Addressing the Negative Health Impact of Rapid Urbanization in Africa 42 SUNDAY, OCTOBER 15

WORKSHOP

WS 01 GENDE R EQUALITY WITHIN

SAAL 10 | ASIA THE GLOBAL HEALT H WORKFORCE 10:00 – 11:30 Working for a new Status Quo

HOSTS

M8 Alliance: Monash University

Women in Global Health

This workshop will examine the global workforce. The panel will provide a brief health workforce with a gender lens and introduction to the topic to provide food will focus on the interplay between gender for thought for the second half of the equal leadership and the advancement session. Following the panel, attendees of health globally. We hope to address will be invited to join smaller breakout questions in this workshop such as: groups where they will be guided through What barriers do di—erent personnel in a case study and a series of thought the global health workforce face and provoking discussion questions which how do institutions, governments, NGOs, enable them to delve deeper into the the private sector and individuals help questions outlined above. to remove those barriers? How do we The breakout sessions will conclude with combine SDG 3 on health, and SDG 5 a brief recap and introduction to a gender on gender equality to develop a strong mainstreaming tool that attendees can gender equal global health leadership utilize in their own work. Each group will at all levels? be provided with the opportunity to An introductory panel will explore both briefly report back on their discussions. barriers and successes that women have This will be an interactive workshop, faced both in leadership and throughout where group discussion based on case their careers, with a focus on political studies and tools will be held after the life, academia, private sector and health introductory panel. PROGRAM 43

CHAIR 15

Sally Theobald , SUN Liverpool School of Tropical Medicine (LSTM) | Chair, Social Science and International Health‹‹| United Kingdom GRAM O Heidemarie Olawunmi Sally Wieczorek-Zeul Oduyebo Theobald PR SPEAKERS Charlotte Rees-Sidhu Monash University | Centre for Heidemarie Wieczorek-Zeul Scholarship in Health Education | Friends of the Global Fund Director | Australia Europe | Vice President | Women’s Experiences Germany in Medical Education Women in Global Health Political Leadership Sonia Singh PwC Strategy& | Senior Director‹‹| Jan Charlotte Kelly Jan Coles Coles Rees-Sidhu Thompson United States of America Monash University | Medicine, Nursing and Health Sciences | Sharyn Tenn Director of Research | International Partnership for Australia Microbicides (IPM) | Senior Challenges for Leadership in Director of External A—airs | Gender Based Violence Educa- United States of America tion for Health Professionals Kelly Thompson Roopa Sonia Sreytouch Roopa Dhatt Women in Global Health | Dhatt Singh Vong Women in Global Health | Gender Specialist | Initiative Director & Co-Founder | United States of America United States of America Topic Case Study – Tana Wuliji Current Status of Women WHO Executive Board World Health Organization in Global Health Leadership Sreytouch Vong (WHO) | Technical O²cer, Olawunmi Oduyebo Cambodia Development Health Workforce | All Things Health Africa (ATHA) | Resource Institute | Cambodia Switzerland Tana Founder | Kenya Barriers and Discrimination Barriers and Discrimination Wuliji Women Leading the Way by Gender in the Cambodian by Gender in the Global in Tech and the Private Sector Health Workforce Health Workforce 44 SUNDAY, OCTOBER 15

WORKSHOP

WS 02 IM PROVING PANDEMIC PREPAREDNESS

SAAL 2 | AMERICA A ND RESPONSE 10:00 – 11:30

HOSTS

M8 Alliance: Charité – Universitätsmedizin Berlin

Heidelberg Institute of Public Health (HIPH)

The number and type of infectious Given that pandemics can devastate disease outbreaks have increased signi- economies and threaten both develop- ficantly over the past 30 years. As global ment and major investments by multi- trade and travel enable humans and nationals and small businesses alike, goods to be more and more mobile, the public and the private sector share the risk of diseases spreading beyond interests in ensuring that global epi- national borders increases. Infectious demics, such as Ebola, are quickly recog- diseases are often mistakenly viewed nized and contained and that global as mere health issues. However, they are endemics, such as HIV and Zika, are potentially grave threats to countries’ sustainably addressed through health security as well as economic and systems. human development. In this session, we will discuss interven- tions and health systems improvements to better prepare countries and the global community for the epidemics and endemics of the future. PROGRAM 45

CHAIR 15

Till Bärnighausen , SUN Heidelberg Institute of Public Health (HIPH) | Director | Germany GRAM O Till Trevor Bärnighausen Mundel PR SPEAKERS

Raymonde Goudou Co´e Harald Nusser Ministry of Health and Public Hygiene | Novartis | Head, Novartis Social Minister | Ivory Coast Business | Germany

Christian Drosten Lothar H. Wieler Charité‹–‹Universitätsmedizin Berlin | Robert Koch Institute |

Institute of Virology Campus President | Germany Raymonde Harald Charité Mitte | Director | Germany Goudou Co²e Nusser

Trevor Mundel Bill & Melinda Gates Foundation | President of the Global Health Division | United States of America

Christian Lothar H. Drosten Wieler 46 SUNDAY, OCTOBER 15

WORKSHOP

WS 03 TA CKLING BARRIERS TO

SAAL 4 | AFRICA CA NCER TREATMENT AND CARE 10:00 – 11:30 Behind the Scenes: The Making of a Successful Multisectoral Collaboration

HOSTS

Access Accelerated

M8 Alliance: Charité – Universitätsmedizin Berlin

F. Ho¼mann-La Roche Ltd.

Cancer is one of the fastest growing account for these partnerships to be noncommunicable diseases (NCDs). impactful? True collaboration requires A coordinated global e—ort between buy in from all stakeholders, and a patients, the biopharmaceutical industry, decision making process that weighs government and civil society is urgent - a diverse set of needs and balances ly needed to address the full range them with the best interests of patients. of barriers to treatment and care, and increase the availability of a—ordable This panel will explore the lessons learned cancer care and access to essential and success factors that communities medicines. across the world need to be aware of to form partnerships that make significant But with so many di—erent barriers and progress in reducing premature deaths needs to address, how are these multi- from NCDs. Speakers from the govern- sectoral collaborations created and what ment, industry, NGOs and patient advo- considerations need to be taken into cacy organizations will participate to share their perspectives. PROGRAM 47

CHAIR 15

Shiulie Ghosh , SUN TRT World | Journalist | Turkey GRAM O SPEAKERS Michael Joseph Baumann Kibachio PR HRH Princess Dina Mired of Jordan Joseph Kibachio Union for International Cancer Control Ministry of Health | Division of (UICC) | President-Elect | Switzerland Noncommunicable Diseases | Head | Overcoming Obstacles for Cancer Kenya Treatment and Care: Collaboration The Role of Government: and the Role of NGOs Addressing Local Challenges with Local Solutions Michael Baumann Thomas B. HRH Princess Dina German Cancer Research Center | Andrew Spiegel Cueni Mired of Jordan Chairman & Scientific Member of the International Alliance of Patients’ Management Board | Germany Organizations | Member of the Can Research Institutions Impact Governing Board | United Kingdom Health Care on a Global Level? – The Role of Patient Groups and Example Cancer Research Patients in Influencing Management of Care Thomas B. Cueni International Federation of Pharma- Shiulie Andrew ceutical Manufacturers & Associations Ghosh Spiegel (IFPMA) | Director General | Switzerland The Role of Industry: The Example of the Access Accelerated Initiative 48 SUNDAY, OCTOBER 15

WORKSHOP

WS 04 EUR OPEAN INITIATIVES FOR

SAAL 5 | OCEANIA HEA LTH RESEARCH AND DEVELOPMENT 10:00 – 11:30

HOSTS

European Commission

Helmholtz Association of German Research Centers e.’V.

Scientific Panel for Health (SPH)

The European Commission’s Scientific A healthier research ecosystem – open, Panel for Health (SPH) is a science-led collaborative, innovative – could continu- expert group based on the provisions of ally deliver solutions for improved health. the Horizon 2020 Specific Programme To further health research across the EU, that has been tasked with helping to the SPH is leading a proposal for com- achieve better health and wellbeing for prehensive policy for health research, all. Although, health and disease know no encompassing broad stakeholder parti- borders, health research is often limited cipation. This WHS workshop o—ers an by national boundaries, resources and opportunity to engage with world leaders priorities. Strategic health research pro - in health research to discuss the potential grammes and international research for European health research to build collaborations have shown success in on its global outreach and collaboration. responding to health priorities, especially in crisis situations. PROGRAM 49

CHAIR 15

Karin R. Sipido , SUN European Commission | Scientific Panel for Health | Chair | Belgium GRAM O Elizabeth Elmar Blackburn Nimmesgern PR SPEAKERS DISCUSSANTS

Elizabeth Blackburn Rupert Gerzer Salk Institute for Biological Studies | Skoltech Center for Translational President | United States of America Biomedicine | Provost | Russia

Depei Liu Chinese Academy of Engineering |

Former Vice President & President Rupert Karin R. of InterAcademy Partnership (IAP) Gerzer Sipido for Health | China

Elmar Nimmesgern European Commission | Deputy Head of Unit Innovative and Personalised Medicine | Belgium

Otmar D. Wiestler Helmholtz Association of German Depei Otmar D. Liu Wiestler Research Centers e.‹V. | President | Germany 50 SUNDAY, OCTOBER 15

WORKSHOP

WS 04’a L ONG-TERM AND END-OF-LIFE CARE

SAAL 4 | AFRICA IN AGING SOCIETIES 11:30 – 13:00 The M8 Alliance Action Initiative Project

HOSTS

M8 Alliance: M8 Alliance: Charité – Universitätsmedizin Berlin National Taiwan University (NTU)

M8 Alliance: M8 Alliance: University of Coimbra University of Montreal

M8 Alliance: Kyoto University

Between 2000 and 2050, the proportion In WHO’s 2016 report, autonomy, includ- of the world’s population aged 60 years ing advanced care planning, has been or over will double from about 11% to 22%. repeatedly identified by older adults as By 2050, Europe will have about 34% of a core component of their wellbeing. its population aged 60 years or over. Taiwan’s Patient Self-Determination Act was legalized in 2016 and will take e—ect In 2000, Japan implemented Long-Term in 2019. Patients can make their own Care (LTC) policy with a new public in- Advance Directive via Advanced Care surance system for LTC. In 2016, Taiwan Planning (ACP) by stating whether they has started a second ten-year LTC Plan wish to accept or refuse life-sustaining aiming to coordinate LTC services and treatments. develop a continuum of care system. We will share the current status of LTC Facing the challenge as ones of the fastest policy in Japan and Taiwan and a frame- aging counties in the world, Kyoto Univer- work of investigating the mechanism sity (KU) and National Taiwan University of integrated LTC service through our (NTU) are now collaborating on the first colla boration between the NTU and KU. Action Initiative project approved by the World Health Summit. PROGRAM 51

CHAIRS 15

Chang-Chuan Chan Fernando Regateiro , SUN National Taiwan University (NTU) | Coimbra University Hospitals | Dean, College of Public Health | Taiwan Chairman of the Board of Directors | Portugal GRAM O Shunichi Fukuhara Chang-Chuan Yvette Kyoto University | Dean, Chan Lajeunesse PR School of Public Health | Japan

SPEAKERS

Shunichi Fukuhara Chih-Yuan Shih Kyoto University | Dean, National Taiwan University (NTU) |

School of Public Health | Japan Director of Health Promotion and Ya-mei Fernando Overview and Progress of Action Management Center | Taiwan Chen Regateiro Initiative Project on Long-Term and Impact of Advanced Care Planning End-of Life Care in Aging Societies policy on End of Life Care in Taiwan

Ya-mei Chen Yvette Lajeunesse National Taiwan University (NTU) | University of Montreal | Professor | Deputy Director, College of Public Health‹| Canada Taiwan The New Challenges of End The Framework of Investigating of Life Medical Care in Québec Kai-Uwe Chih-Yuan the Mechanism of Integrated Eckardt Shih Long-Term Care Service

Kai-Uwe Eckardt Charité – Universitätsmedizin Berlin | Director, Division of Nephrology and Internal Intensive Care Medicine | Germany

Chronic Kidney Disease – Shunichi A Challenge for Ageing Populations Fukuhara 52 SUNDAY, OCTOBER 15

PANEL DISCUSSION

PD 02 N ONCOMMUNICABLE DISEASES Examining Global Health Priorities SAAL 6 | EUROPE 13:00 – 14:30

HOSTS

The NCD Alliance

Sanofi

As the leading cause of death and disabil- health systems to better respond to ity worldwide, noncommunicable diseases NCDs. Many of the interventions recom- (NCDs) are now widely recognized as a mended by the WHO, the so-called major challenge to health and sustainable ‘best buys for NCDs’, are very cost-e—ec- human development in the 21st century. tive even for LMICs, with price tags as low Half of those who die of NCDs are in the as 0.20 USD per capita / year for popula- prime of their productive years, and thus, tion-based policies and other measures. the disability imposed and the lives lost Despite previous high-level commitments are adversely a—ecting communities, to strengthen national NCD responses businesses and governments through and evidence-based recommendations losses in macroeconomic productivity, for cost-e—ective action, progress at national income, healthcare budgets and national levels remains insu²cient and household income. uneven. At the current pace, countries While the economic and social burden will not achieve the global ‘25 by 25’ NCD of NCDs is immense, the financial invest- goal. In view of the upcoming 2018 UN ment to alleviate this burden on patients, High-Level Meeting on NCDs, there is a families and carers is comparatively small. need to address common barriers and Immediate actions to reduce the burden bottlenecks and explore common success caused by NCDs include action to address factors and catalytic strategies applicable the main risk factors (tobacco use, harm- to di—erent economic settings to support ful use of alcohol, unhealthy diets, and the implementation of e—ective NCD physical inactivity), and strengthening prevention policies and sustainable health systems for NCDs globally. PROGRAM 53

CHAIR 15

Andrew Jack , SUN Financial Times | Editor | United Kingdom GRAM O Katie HRH Princess Dina Dain Mired of Jordan PR SPEAKERS

HRH Princess Dina Mired of Jordan Joseph Kibachio Union for International Cancer Control Ministry of Health | Division of (UICC) | President-Elect | Switzerland Noncommunicable Diseases | Head | Introductory Keynote Kenya

Katie Dain Stefan Oelrich

The NCD Alliance | CEO | Sanofi | Head Global Diabetes Franchise | Gauden Stefan United Kingdom Senior Vice President | Germany Galea Oelrich

Gauden Galea Rajitha Senaratne WHO Regional O²ce for Europe | Ministry of Health, Nutrition and Division of Noncommunicable Diseases Indigenous Medicine | Minister | and Health Promotion | Director | Sri Lanka Denmark

Andrew Rajitha Jack Senaratne

Joseph Kibachio 54 SUNDAY, OCTOBER 15

WORKSHOP

WS 05 AFTE R THE US COP21 WITHDRAWAL The Foreseen Impact on Health SAAL 10 | ASIA 13:00 – 14:30

HOSTS

Centre Virchow-Villermé for Public Health Paris-Berlin

German National Academy of Sciences Leopoldina e.’V.

M8 Alliance: University of Geneva

The US withdrawal from the Paris Agree- This session will explore the health im- ment came as a shock, and could have pacts of climate change as foreseen since worrying environmental consequences, the 2015 Paris Agreement. Three main but not only. topics will be addressed: Health as an argument in the climate change nego- Climate change is indeed central to all tiations; Climate change, migration and the major challenges of the 21st century: health; Climate change, food security the rising temperature, extreme weather and health. events and greenhouse gas emission have direct or indirect e—ects on food security, urban policies, or even migra- tion. As well, climate change poses an important threat to our health. However, tackling climate change could represent “the greatest global health opportunity of the 21st century”. PROGRAM 55

CHAIRS 15

Anneliese Depoux Jörg Hacker , SUN Centre Virchow-Villermé for Public German National Academy of Sciences Health Paris-Berlin | Co-Director | France Leopoldina e.‹V. | President | Germany GRAM O Anneliese Corinne Depoux Kowalski PR SPEAKERS

Antoine Flahault Joacim Rocklöv University of Geneva | Lancet Countdown | Umeå University | Institute of Global Health | Director | Associate Professor in Epidemiology | Switzerland Sweden Climate Change and Lancet Countdown: Tracking Progress Emerging Infectious Diseases on Health and Climate Change Antoine Joacim François Houllier Muhammad H. Zaman Flahault Rocklöv Université Sorbonne Paris Cité | Boston University | President | France Professor of Biomedical Engineering | Climate Change and Food Security United States of America Climate Migration and Health Corinne Kowalski Centre Virchow-Villermé for Public Health Paris-Berlin | International

A—airs Manager | France Jörg Muhammad H. Health as an Argument Hacker Zaman in the Climate Negotiations

François Houllier 56 SUNDAY, OCTOBER 15

WORKSHOP

WS 06 ARTIFICIAL INTELLIGENCE IN HEALT H The Beginning of a Primary Care Revolution SAAL 2 | AMERICA 13:00 – 14:30

HOST

Fondation Botnar

This session will present the views of Questions that will be tackled: leading change-makers in Artificial Intelligence (AI) that o—er solutions for • How can AI ensure healthy lives and transforming health access, information promote well-being for all children by and diagnostics for the wellbeing of 2030? children. • How can AI transform and revolutionize The session will set out to: access, information and diagnostics through a multi-stakeholder approach 1) identify avenues for achieving the of tech giants, startups, investors, vision of universal free access to quality researchers, and developers from every health information and diagnostics corner of the AI ecosystem? powered by AI, and 2) demonstrate concrete examples • What do these solutions look like and including a short demonstration of how can they be implemented and “AI and rare diseases” through practical scaled? examples. • What are critical issues for planning and implementing such solutions? PROGRAM 57

CHAIR 15

Stefan Germann , SUN Fondation Botnar | CEO | Switzerland GRAM O SPEAKERS Stefan Arthur Germann Kaindl PR Sabine Gless Arthur Kaindl Faculty of Law of Basel University | Siemens Healthcare | Digital Health Criminal Law and Criminal Procedure | Services | General Manager | Professor | Switzerland Germany Legal and Ethics in Artificial Health Digitalization Intelligence Hassan Mshinda

Martin Hirsch Tanzania Commission for Science Sabine Hassan Ada Health | Founder and and Technology (COSTECH) | Gless Mshinda Chief Scientific O²cer | Germany Director General | Tanzania Health Diagnostics Innovation, Digital Applications and Public-Private Partnerships for Sustainable Development in Tanzania

Martin Hirsch 58 SUNDAY, OCTOBER 15

WORKSHOP

WS 07 D EFINING AN

SAAL 4 | AFRICA EU GLOBAL HEALT H STRATEGY 13:00 – 14:30 Advancing Policy Coherence and Partnership

HOST

M8 Alliance: London School of Hygiene and Tropical Medicine (LSHTM)

In 2010 the EU Foreign A—airs Council In July 2017 the EU adopted its new adopted the EU Council Conclusions on development consensus, which includes Global Health. It took as its starting point references to the SDG health goals. The a commitment to equity and Health in all biggest challenge however will be how policies and provided a framework for EU other EU policies and investments – input regarding SDG cooperation. It was trade, research. foreign a—airs, agriculture based upon an intersectoral Commission etc., will contribute to the determinants Communique. Now that the Agenda 2030 of global health and policy coherence for has been adopted it is time to revisit the SDG achievement. This workshop will aim EU’s role in global health. The global to identify strategic steps to reinvigorate environment has changed significantly the EU’s role in global health. and new priority issues and key actors have emerged. PROGRAM 59

CHAIR 15

Eero Lahtinen , SUN Permanent Mission of Finland in Geneva | Counsellor | Switzerland GRAM O Thea Robert Emmerling Madelin PR SPEAKERS

Thea Emmerling Robert Madelin Delegation of the European Union Fipra International | Chairman | Belgium to the United States | Health, Food Global Health Futures: Safety, and Consumer A—airs Section | Making Europe a Positive Player Minister Counselor | United States Martin McKee of America London School of Hygiene and The 2010 Commission Communication Björn Martin Tropical Medicine (LSHTM) | Kümmel McKee and 2011 Council Conclusion on the Professor of European Public Health | EU role in Global Health: What did we United Kingdom Decide? What have we Achieved? Global Health: If not Europe, who? Björn Kümmel If not now, when? Bundesministerium für Gesundheit / Federal Ministry of Health (BMG) | Deputy Head of Division Global Health | Germany Eero Lahtinen Challenges and Perspectives for a Stronger Role of the EU in Global Health – Practical Experiences from the WHO 60 SUNDAY, OCTOBER 15

WORKSHOP

WS 08 T HE HUMAN CELL ATLAS

SAAL 5 | OCEANIA A S A BASIS FOR NOVEL THERAPIES 13:00 – 14:30

HOST

Max Delbrück Center for Molecular Medicine (MDC)

In October 2016, a a collaborative com- A complete Human Cell Atlas would give munity of world-leading scientists met us a unique ID card for each cell type, a in London, and discussed how to build a three-dimensional map of how cell types Human Cell Atlas‹–‹a collection of maps work together to form tissues, knowledge that will describe and define the cellular of how all body systems are connected basis of health and disease. and insights into how changes in the map influence health and disease. It would Cells are the most fundamental unit of allow us to identify which genes associ- life, yet we know surprisingly little about ated with disease are active in our bodies them. They vary enormously within the and where, and analyze the regulatory body, and express di—erent sets of genes. mechanisms that govern the production Without maps of di—erent cell types and of di—erent cell types. where they are located in the body, we cannot describe all their functions and This has been a key challenge in biology understand the biological networks that for more than 150 years. New tools such direct their activities. as single-cell genomics have put it within reach. It is an ambitious but achievable goal, and requires an international com- munity of biologists, clinicians, technolo- gists, physicists, computational scientists, software engineers and mathematicians. PROGRAM 61

CHAIRS 15

Martin J. Lohse Nikolaus Rajewsky , SUN Max Delbrück Center for Molecular Max Delbrück Center for Molecular Medicine | Chair of the Board of Medicine | Systems Biology of Directors and Scientific Director | Gene Regulatory Elements | GRAM O Germany Head of the Group | Germany Martin J. Fabian Lohse Theis PR

SPEAKERS

Joachim L. Schultze Jörg Vogel University of Bonn | Genomics & University of Würzburg | Immunoregulation, LIMES-Institut | Institute for Molecular Infection Biology | Department Head | Germany Director | Germany Nikolaus Jörg Fabian Theis Rajewsky Vogel Helmholtz Zentrum Munich | Group Leader Machine Learning | Head of Institute | Germany

Joachim L. Schultze 62 SUNDAY, OCTOBER 15

PANEL DISCUSSION

PD 03 PR ECISION MEDICINE

SAAL 6 | EUROPE A ND POPULATION HEALT H 15:00 – 16:30 Forging a Consensus

HOSTS

Berlin Institute of Health (BIH)

M8 Alliance: Institut de Recherches Cliniques de Montréal (IRCM)

Max Delbrück Center for Molecular Medicine (MDC)

The concept and practice of precision This announcement and approach has medicine took center-stage during the led to a variety of responses, from enthu- 2015 State of the Union address by U.S. siastic expectation to explicit skepticism President Barack Obama, when he pro- about potential health benefits, limita- claimed the goal of funding a national tions, and return on investment. Will the “precision medicine initiative.” The stated precision medicine approach become mission of this initiative was clear: “to a valuable ally in improving population enable a new era of medicine through health or will its e—ects be negligible? research, technology, and policies that empower patients, researchers, and The session specifically aims to see providers to work together toward de- whether a consensus can be forged velopment of individualized treatments.” between these disparate perspectives The goal of precision medicine is there- on this contentious issue. fore to approach disease treatment and prevention by taking into account the individual variability in environment, lifestyle and genes for each person. PROGRAM 63

CHAIR 15

Martin J. Lohse , SUN Max Delbrück Center for Molecular Medicine | Chair of the Board of Directors and Scientific Director | GRAM O Germany Elizabeth Martin J. Blackburn Lohse PR

SPEAKERS

Elizabeth Blackburn Tarik Möröy Salk Institute for Biological Studies | Montreal Clinical Research Institute President | United States of America (IRCM) | President and Scientific Director | Canada Elena Bonfiglioli Elena Tarik Microsoft Corporation | Senior Director Andreas Radbruch Bonfiglioli Möröy Health Industry, Europe Middle East German Center for Research of Africa (EMEA) | United States of America Rheumatism (DRFZ) | Scientific Director | Germany Erwin Paul Böttinger University of Potsdam | Digital-Engineering Faculty | Specialist for Digital Health | Germany

Erwin Paul Andreas Böttinger Radbruch 64 SUNDAY, OCTOBER 15

WORKSHOP

WS 09 MI GRATION AND

SAAL 10 | ASIA GLOB AL HEALT H POLICY 15:00 – 16:30

HOSTS

M8 Alliance: Charité – Universitätsmedizin Berlin

M8 Alliance: London School of Hygiene & Tropical Medicine (LSHTM)

M8 Alliance: Sapienza University

The arrival of migrants from di—erent of perception and attitudes from both cultures has been and continues to be a sides represent a particular challenge major challenge to healthcare systems in within the framework of globalization. receiving countries. In particular, health- This workshop aims at a taking stock of care providers in those countries have di—erent experiments in di—erent regions to take into account in their daily work and countries having had to deal with questions of diversity and identity in the integration of substantial numbers relation to their own cultural practices. of migrants. A global comparison might This can also lead to a clash of values lead to practical conclusions for public not least in relation to gender. Questions health policies. PROGRAM 65

CHAIRS 15

Johanna Hanefeld H.E. Reinhard Schäfers , SUN London School of Hygiene & Tropical World Health Summit | Ambassador | Medicine (LSHTM) | Associate Professor Germany of Health Policy and Systems | GRAM O United Kingdom Giannis Joachim Baskozos Seybold PR

SPEAKERS DISCUSSANTS

Giannis Baskozos Luciano Saso Ministry of Health | Public Health | Sapienza University of Rome | Secretary General | Greece Faculty of Pharmacy and Medicine | The Immunization in Migration Vice-Rector for European University and Global Health Policy Networks | Italy Johanna Heidi Hanefeld Stöckl Walter Ricciardi Ahmad Tarakji National Institute of Health | Syrian American Medical Society | President | Italy President | United States of America Migrants and Health: An Italian Perspective

Joachim Seybold Charité – Universitätsmedizin Berlin | Walter Luciano Deputy Medical Director | Germany Ricciardi Saso Health Care for Refugees in Berlin: Challenges and New Concepts

Heidi Stöckl London School of Hygiene & Tropical Medicine (LSHTM) | Associate | United Kingdom

Mobile Populations, Violence H.E. Reinhard Ahmad and Health Schäfers Tarakji 66 SUNDAY, OCTOBER 15

WORKSHOP

WS 10 CA NCER IN AFRICA

SAAL 2 | AMERICA 15:00 – 16:30

HOSTS

M8 Alliance: Charité – Universitätsmedizin Berlin

Pfizer Inc

This session is based upon the experi- coordinated actions with Public-Private ences and recommendations of an inter- Partnerships to make necessary progress. national expert group which published The session will reflect on the call to a unique report regarding the state of action which was issued by the authors oncology within the African continent. and how to best pursue this within the It is impossible to avoid the conclusion fastest possible time frame, taking into that there is an urgent need for major account all stakeholders involved. PROGRAM 67

CHAIRS 15

Manfred Dietel Andreas Penk , SUN Charité – Universitätsmedizin Berlin | Pfizer Germany | Oncology International Institute for Pathology | Director | Developed Markets | Regional President | Germany Germany GRAM O Peter Twalib Boyle Ngoma PR

SPEAKERS

Peter Boyle Twalib Ngoma International Prevention Research Open Road Cancer Institute (ORCI) | Institute (iPRI) | President | France Executive Director | Tanzania

Markus Kosch Pfizer Pharma | Oncology Portfolio, Manfred Andreas Europe, Japan & Developed Asia | Dietel Penk Vice President | Germany

Markus Kosch 68 SUNDAY, OCTOBER 15

WORKSHOP

WS 11 ACCESS TO MEDICINES THROUGH

SAAL 4 | AFRICA I NNOVATION 15:00 – 16:30 The Role of Politics in Developing Lifesaving Scientific Advancements Available for All

HOSTS

M8 Alliance: The Graduate Institute of International and Development Studies

The aim of this workshop is to identify Several initiatives including the ‘Lancet how political stakeholders should re- Commission on Access to Medicines’ and spond to the issue of supply shortages a high level panel endorsed by the UN of essential medicines, an issue a—ecting Secretary General have analyzed gaps both developing and developed coun - and possible solutions forward in existing tries today. Despite the pharmaceutical responses. in dustry, research and development being globally interwoven, availability of The latest UN Report on Access to essential medicines remains a key issue. Medicine regarding conclusions on joint priority actions will be presented. The Policy responses require concerted action ensuing discussion will focus on expec- and coordinated approaches. In line with tations regarding the Fair Prices Forum, SDG 3, governments have committed to provision of resources, global and local health and wellbeing as a universal objec- regulation and implementation, as well tive, ensuring access for all individuals to as possibilities for follow up actions. safe, e—ective and a—ordable medicines. PROGRAM 69

CHAIR 15

Susanne Weber-Mosdorf , SUN World Health Organization (WHO) | Former Assistant Director General | Germany GRAM O Ruth Suerie Dreifuss Moon PR

SPEAKERS

Ruth Dreifuss Rüdiger Krech The United Nations Secretary-General’s World Health Organization (WHO) | High-Level Panel on Access to Medicines | O²ce of the Assistant Director-General | Co-Chair | Switzerland Health Systems and Innovation | Introductory Keynote: Director | Switzerland The Way Forward – Conclusions from Franz Susanne Suerie Moon Knieps Weber-Mosdorf The United Nations Secretary-General’s Graduate Institute of International High-Level Panel on Access to and Development Studies | Director Medicines Report of Research, Global Health Centre Franz Knieps and Visiting Lecturer | Switzerland BKK Governing Body | Member of the Board | Germany

Rüdiger Krech 70 SUNDAY, OCTOBER 15

WORKSHOP

WS 12 N EW APPROACHES IN

SAAL 5 | OCEANIA CHA LLENGING DEMENTIA 15:00 – 16:30

HOSTS

M8 Alliance: Charité – Universitätsmedizin Berlin

World Dementia Council (WDC)

World Stroke Organization (WSO)

Progress and dementia poses a paradox: The Global World Council does recog - providing growing insights into patho- nize this and as the highest coordinating physiology but not a single disease body in the fight against dementia, modi fying drug. The current reductionist encom passes a diverse, comprehensive approach needs to be complemented portfolio and clear priorities. One of the by an understanding of complex systems immediate priorities is to act on the grow- and the most powerful determinant of ing evidence that by preventing stroke we cognitive impairment, namely aging. can also prevent some dementias, since stroke doubles the chances of develop- Most of our understanding of dementia ing dementia. All the major organizations derives from studies of Western popu- dealing with stroke and dementia have lations that may di—er from other popula- endorsed the joint prevention and this tions, not only culturally but genetically approach o—ers a real possibility to do and biologically. Dementia, although something about it now. a global problem, manifests di—erently in di—erent parts of the world. With current knowledge, we are at the cusp of a transformational change of our approach to the two greatest threats to the brain, stroke and dementia. PROGRAM 71

CHAIRS 15

Karl Max Einhäupl Vladimir Hachinski , SUN Charité – Universitätsmedizin Berlin | World Stroke Organization | Chair, CEO | Germany Joint Prevention of Stroke and Dementia | Canada GRAM O Suvarna Yves Alladi Joanette PR

SPEAKERS

Suvarna Alladi Yves Joanette University of Cambridge | CIHR Institute of Aging | Scientific Director National Institute of Mental Health University of Montreal / World Dementia and Neuro Sciences (NIMHANS) | Council | Professeur Titulaire / Chair | Professor | India Canada Dementia in the Developing World New Approaches for Dementia: Karl Max Zaven Einhäupl Khachaturian A Global Perspective Karl Max Einhäupl Charité – Universitätsmedizin Berlin | Zaven Khachaturian CEO | Germany Campaign to Prevent Alzheimer’s Next Steps Forward Disease by 2020 | President | United States of America Vladimir Hachinski Dementia: The Urgent Need World Stroke Organization | for New Approaches Chair, Joint Prevention of Stroke Vladimir and Dementia | Canada Hachinski Preventing Stroke and some Dementias now 72 SUNDAY, OCTOBER 15

KEYNOTE

KEY 01 O PENING CEREMONY SAAL 1 RUDOLF VIRCHOW 17:00 – 18:30

HOST

M8 Alliance: Charité – Universitätsmedizin Berlin PROGRAM 73

CHAIRS 15

Hélène Boisjoly Detlev Ganten , SUN University of Montreal | Faculty of World Health Summit | President | Medicine | Dean & Acting President Germany of the World Health Summit 2017 | GRAM O Canada Hermann Christoph Gröhe Franz PR

SPEAKERS

Hermann Gröhe Roger D. Kornberg Bundesministerium für Gesundheit / Stanford University | School of Medicine | Federal Ministry of Health (BMG) | Structural Biology | Federal Minister | Germany Professor, Nobel Laureate | Werner Joanne Joanne Liu United States of America Baumann Liu Médecins Sans Frontières | Christoph Franz International President | Switzerland Roche Holding Ltd | Chairman, Werner Baumann Board of Directors | Switzerland Bayer AG | CEO | Germany

Hélène Roger D. Boisjoly Kornberg

Detlev Ganten 74 PROGRAM, MONDAY, OCTOBER 16, 2017 75

PROGRAM

MONDAY, OCTOBER 16 76 MONDAY, OCTOBER 16

PANEL DISCUSSION

PD 04 BIG DATA FOR HEALTH GOVERNANCE Benefits, Frameworks & Ethics SAAL 6 | EUROPE 9:00 – 10:30

HOSTS

M8 Alliance: Monash University

SAP SE

Data is now a cornerstone of the health- This session will explore the opportunities care industry. It documents everything for Big Data to assist governments and from blood pressure readings and surgi- health care providers in delivering maxi- cal records to insurance claims, immuni- mum benefit to society. Big Data will drive zation histories, patient demographics fact-based decisions by policy makers and receipts of payment. But even though and shape how health systems address Big Data can bridge the gap between societal and global challenges in both in healthcare delivery and population health developed and developing economies. and improve many health outcomes The increased scope, detail and availa- through enhanced methods of research, bility of patient and population data will the detailed collection of personal infor- also influence the broader debate around mation poses ethical, regulatory and data governance and the associated technical challenges. ethical issues. Our panelists will illustrate the discussion with some case studies of health data uses to help clinical practice management, surveillance, health system management, and research and inno- vation. PROGRAM 77

CHAIR

Ross Coppel Monash University | Faculty of Medicine, Nursing and Health Sciences | Deputy Dean and Director of Research Francesca Maxim Colombo Fedorov

SPEAKERS

Francesca Colombo Albena Kuyumdzhieva Organization for Economic Cooperation European Commission | DG Research & , MON 16 and Development (OECD) | Innovation | Programme Manager- Head of Health Division | France Research / Ethics Review | Belgium

Embedding Big Data within the Health Big Data Oversight and Ethics GRAM O System – Health Data Governance Ross Albena Ola Rosling Coppel Kuyumdzhieva PR David Delaney, MD Gapminder Foundation | SAP SE | Chief Medical O²cer | President & Co-Founder | Sweden United States of America Big Data for a Fact-Based Worldview Big Data in the Developed World Context

Maxim Fedorov Skolkovo Institute of Science David Ola and Technology (Skoltech) | Delaney Rosling Center for Computational and Data- Intensive Science and Engineering | Director | Russia How can Big Data help to Answer the Big Health Questions? 78 MONDAY, OCTOBER 16

WORKSHOP

WS 13 I NNOVATIVE NEW WAYS

SAAL 10 | ASIA IN FIGHTING NTDS 9:00 – 10:30

HOSTS

German Network against Neglected Tropical Diseases (DNTDs)

German Association of Research-based Pharmaceutical Companies (VFA)

Neglected Tropical Diseases (NTDs) are philanthropic, pharmaceutical, govern- a group of tropical infections that a—ect mental, and nongovernmental organiza- the world’s poor and marginalized popu- tions are a must. lations. According to the World Health Organization, more than a billion people Refined diagnostic tests and techniques or one-seventh of the global population allow NTD-programs to achieve success. su—er from one or more tropical infec- For example: diagnostic testing for lym - tious diseases. phatic filariasis (LF) is now more sensitive and cost-e²cient, thanks to a partnership Availability of treatment, technology among academic, philanthropic, pharma- transfer, scientific collaboration and ceutical, governmental, and nongovern- knowledge sharing but also research and mental organizations. The Liverpool development are important to move School of Tropical Medicine (LSTM) is forward against some of the world’s most working on new macrofilaricides acting debilitating and stigmatizing diseases. through an anti-Wolbachia mechanism. Partnerships and collaborations can play Together with Abbvie DNDi is following a crucial role in solving intractable chal- up on screening hits for parasites caus - lenges and tackling neglected diseases. ing visceral leishmaniasis and Chagas’ Refined diagnostic tests and techniques disease, and nematodes causing river allow NTD-programs to achieve success. blindness and lymphatic filariasis. More sensibility, cost-e²ciency and good partnerships among academic, PROGRAM 79

CHAIRS

Carsten Köhler Aluisio Cotrim Segurado University Hospital Tübingen | University of São Paulo | Institute of Tropical Medicine | Faculty of Medicine | Department of Center of Competence | Director | Infectious Diseases | President | Germany Brazil Achim Jutta Hörauf Reinhard-Rupp

SPEAKERS

Achim Hörauf Jutta Reinhard-Rupp , MON 16 University Hospital Bonn | Institute of Merck KGaA, Darmstadt | Global Health Medical Microbiology, Immunology and Institute | Head | Switzerland

Parasitology | Director | Germany What are the Challenges of the Private GRAM O What could be Game Changers in Sector to Fight Schistosomiasis? Carsten Aluisio Cotrim Köhler Segurado PR Filarial Elimination Programs? Monique Wasunna Humphrey D. Mazigo Drugs for Neglected Diseases initiative Catholic University of Health and Allied (DNDi) Africa | Director | Kenya Sciences | Senior Lecturer | Tanzania Strengthening Capacity for Visceral How to Build up New Partnerships Leishmaniasis Clinical Research in for Innovation? Africa: Challenges and Opportunities

David Molyneux Humphrey D. Monique Liverpool School of Tropical Medicine Mazigo Wasunna (LSTM) | Emeritus Professor and Senior Professioral Fellow | United Kingdom The Changing NTD Paradigm – A Core Cross Cutting Component of the SDGs

David Molyneux 80 MONDAY, OCTOBER 16

WORKSHOP

WS 14 N EW STRUCTURES FOR

SAAL 2 | AMERICA TRA NSLATIONAL RESEARCH 9:00 – 10:30 Better Ways to Deliver Precision Medicine

HOSTS

German Centers for Health Research (DZG)

Helmholtz Association of German Research Centers e.’V.

Translational research is part of a bidirec- Starting from large data sets acquired tional continuum in which research find - in the clinics, patterns can be identified ings are moved from the researcher´s that link proteins or gene changes bench to the patient´s bedside, but also that can form the bases to stratifying backwards from clinical findings into disease phenotypes. With the aim of mechanistic research. Development of better diag nostics and treatments, new new diagnostic and informatics methods structures in research and health care has seen an increasing trend towards more are being experimented. International personalized therapeutic approaches. experts on neurodegenerative diseases Information on the individual´s genomic / (Prof. Pierluigi Nicotera, Germany), transcriptomic profiles, in combination cancer (Prof. Alexander Eggermont, with lifestyle and environmental factors France) diabetes (Prof. Henning Beck- are integrated to guide medical decision Nielsen, Denmark) and internal medicine in terms of prevention, diagnosis and (Prof. Wieland Voigt, Germany) were treatment of disease. The advent of big invited to present their view on trans- data analysis is also o—ering a reverse lational research as well as to highlight approach to personalized medicine. new structures designed to deliver better precision medicine. PROGRAM 81

CHAIR

Michael Baumann German Cancer Research Center | Chairman & Scientific Member of the Management Board | Germany Michael Pierlugi Baumann Nicotera

SPEAKERS

Henning Beck-Nielsen Pierlugi Nicotera Odense University Hospital | German Center for Neurodegenerative , MON 16 Head of the Department Diseases (DZNE) | Director | Germany of Endocrinology | Denmark German Landscape

Individualized Treatment of Patients of Translational Research GRAM O with Type 2 Diabetes Based on Henning Wieland Wieland Voigt Beck-Nielsen Voigt PR Pathophysiology Siemens Healthineers | Alexander Eggermont Chief Medical O²cer | Germany Gustave Roussy Comprehensive Cancer From Basic Research to Clinical Center | Director General | France Innovation – An Industry Perspective Cancer Core Europe: A Structured Sustainable Model for Open Science, Translational Research, and Training Alexander Eggermont 82 MONDAY, OCTOBER 16

WORKSHOP

WS 15 DIA BETES, METABOLISM & OBESITY Driving Actions for Healthier Lives SAAL 4 | AFRICA 9:00 – 10:30

HOSTS

M8 Alliance: Charité – Universitätsmedizin Berlin

Sanofi

In 2015 it was estimated that globally Despite the launch of innovative treatments 415 million adults have diabetes, by 2040 and solutions during the last decades this number will rise to 642 million. 1 in 2 people are still su—ering. 1 out of 2 is not people with diabetes are undiagnosed. on target. Human and financial resources But Diabetes is not only a burden for are needed to cover the needs for infor- patients it is becoming a major burden mation, support and complications. for healthcare systems. To either prevent people to become The increased number of diabetic pa- diabetics or to help people with already tients coincides with changes in lifestyle established diabetes to live full, healthy factors (nutrition, physical activity, sleep, lives comprehensive solutions have to be stress) overlaid on underlying predis- developed which combine devices, soft - posing factors and pathophysiological ware, medicine, and professional care. mechanisms (genes, epigenetics, beta A multi-stakeholder approach is needed. cell dysfunction, insulin resistance, in- flammation). Looking closer at one of the The workshop discusses the outlook into risk-factors, Obesity, we estimate that the future, opportunities we see, best around 224 million school-age children practices we know, and actions we need are overweight, making this generation to take to make it happen. the first predicted to have a shorter lifespan than their parents. Let’s shape the future of healthcare together! PROGRAM 83

CHAIRS

Ricardo Baptista Leite Gilles Litman Portuguese Republic | Sanofi SA | Global Integrated Care, Member of the Parliament | Portugal Diabetes Cardio-Vascular |

Chairman | France Ricardo Laura Baptista Leite Quinn

SPEAKERS

Ricardo Baptista Leite Laura Quinn

Portuguese Republic | IDF Europe Young Diabetes Advocate | , MON 16 Member of the Parliament | Portugal Final Year Medical Student, University of Birmingham | United Kingdom The Public Health & Political View GRAM The Patients View O Stefanie Gerlach Stefanie Johanna Gerlach Ralston PR diabetesDE – German Diabetes Aid | Johanna Ralston Director of Health Policy | Germany World Obesity Federation | CEO | The Health Policy View United Kingdom The Civil Society View Gilles Litman Sanofi SA | Global Integrated Care, Joachim Spranger Diabetes Cardio-Vascular | Charité – Universitätsmedizin Berlin | Chairman | France Department of Endocrinology and The Health & Tech Industry View Metabolic Diseases | Director | Germany Gilles Joachim Litman Spranger The Scientific View 84 MONDAY, OCTOBER 16

WORKSHOP

WS 16 GLOB AL HEALT H SECURITY ENGAGEMENT

SAAL 5 | OCEANIA IN CONFLICT AND CRISIS SITUATIONS 9:00 – 10:30

HOSTS

Bundeswehr Command and Sta¼ College

Center for Global Health Engagement (CGHE)

Harvard Medical School

King’s College London

Global Health depends more than ever on and support to prevent a collapse of the e²ciency and outcome of all involved the health system and with it one of the global and regional actors. One of them, pillar of human security. Additionally, the military, with their unique and specific nations with ine—ective health systems capabilities is assuming more and more can struggle to form e—ective bilateral tasks in the health sector with the inten- or multilateral partnerships to address tion support security and stability during pandemics, bioterrorism or health-related or post-conflict situations. Specifically, environmental crises that cross borders. during crisis and conflict, the health sector is facing all kind of threats to their work- This workshop highlights critically, the force, financing, infrastructure, and infor - active or passive role of the military in mation systems, that require protection Global Health Security. PROGRAM 85

CHAIRS

Jillann Farmer Christian Haggenmiller United Nations | Bundeswehr Command and Director, Medical Services Division | Sta— College | Lecturer | United States of America Germany Margaret Christian Bourdeaux Haggenmiller

SPEAKERS

Margaret Bourdeaux Feda Mohammad Paikan Harvard Medical School | Instructor in Ministry of Public Health | , MON 16 Medicine | United States of America Deputy Minister | Afghanistan

Major General Martin Bricknell Richard Sullivan GRAM

Headquarters Joint Forces Command | Kings College London | Director, Institute Martin Feda Mohammad O

HQ Surgeon General | Acting Surgeon of Cancer Policy and Co-Director of Bricknell Paikan PR General | United Kingdom King’s Conflict & Health Research Group | United Kingdom Lieutenant General Patrick Godart French Ministry of Defence | Inspector General of the Military Medical Services | France

Jillann Richard Farmer Sullivan

Patrick Godart 86 MONDAY, OCTOBER 16

KEYNOTE

KEY 02 HEA LT H POLICY IN THE G7/G20 SAAL 1 The Future of Global Health Governance RUDOLF VIRCHOW 11:00 – 12:30

HOST

M8 Alliance: Johns Hopkins Bloomberg School of Public Health

Healthcare has developed into a key The health governance issues inherent policy issue that is discussed at both in the Sustainable Development Goals national and international levels. In 2017, have underlined how increasing financial the G20 will for the first time include and political commitments are central a meeting of national Health Ministers to solving global health challenges in a forum set to cover topics like health which must be dealt with at the highest security and antimicrobial resistance. political level. PROGRAM 87

CHAIR

Michael J. Klag Johns Hopkins Bloomberg School of Public Health | Professor & Former Dean | United States of America Dean Georg Jamison Schütte

SPEAKERS

Dean Jamison Georg Schütte University of California, San Francisco | Bundesministerium für Bildung und , MON 16 Professor Emeritus | Forschung / Federal Ministry of United States of America Education and Research (BMBF) |

Directions for Development State Secretary | Germany GRAM O Cooperation in Health: Widening the Scope of Global Health Neil Anna Babette Jordan Stier PR Financing Global Public Goods Research – Looking beyond G7 and G20

Neil Jordan Anna Babette Stier Microsoft | Health Worldwide | Bundesministerium für Gesundheit / General Manager | Federal Ministry of Health (BMG) | United States of America European and International Health Policy | Deputy Director-General | Germany The New Role of Health in the G20 – Building Resilience, Improving Sustain- Michael J. Klag ability, Assuming Responsibility 88 MONDAY, OCTOBER 16

PANEL DISCUSSION

PD 04a T HE BEAUTY OF IMPACT Social Tech Pioneers in Public Health SAAL 6 | EUROPE 11:00 – 12:30

HOST

Bayer Science & Education Foundation

This session showcases impact pioneers never imagined. On stage are tech found- from all continents who have developed ers and health activists who have dared new solutions for the big challenges in to brave the unknown for the purpose public health and social medicine. It is a of shaping the future of humanity. They tribute to those courageous men and are icons of progress. Let them inspire women whose hunger for breakthroughs you for social innovation and progress in has enabled them to excel in spheres public health.

CHAIR

Thimo V. Schmitt-Lord Bayer Foundations | CEO | Germany

C PROGRAM 89

SPEAKERS

Martin Aufmuth Kalana Prasad One Dollar Glasses Maduwage Association | Founder & Snake Rapid | Inventor | Director | Germany Sri Lanka Martin Brian Bhaumik Marc Buckley Mary Matthews Kalana Prasad- Aufmuth Gitta Maduwage Sanghvi ANJA | Founder and Prompt by Memrica | CEO | Germany Founder | United Kingdom István Deák Braille Ring by Tetragon | Margaret Nanyombi Co-Inventor and CEO | BVKit by HerHealth | , MON 16 Austria Inventor, Founder‹&‹CEO |

Uganda GRAM Carsten Dierkes O SANI SOLAR by 3P Tech Harald Neidhardt Marc André Mary Thimo V. Buckley Habisch Matthews Schmitt-Lord PR Filter Systems GmbH | RFRC by MLove & Cisco | Germany Co-Founder | Germany – Greece – Syria Brian Gitta Matibabu | Inventor & Bhaumik Sanghvi Co-Founder | Uganda iBreastExam by UE LifeSciences | André Habisch Founder & CEO | Catholic University USA – India Eichstätt-Ingolstadt | István Frank Margaret Raphael Germany Raphael Schönweitz Deák Ho—mann Nanyombi Schönweitz RSO Shift GmbH | Frank Ho¼mann Co-Founder | discovering hands | Germany – Uganda – Founder & CEO | Tanzania – India Germany – India – Austria – Colombia – Akanksha Vyas Mexico FITED by FITED Inc. | Co-Founder | Christian Keller Carsten Christian Harald Akanksha USA – India – Turkey – DOCTOR DIAL by Dierkes Keller Neidhardt Vyas Poland African Founders | Co-Founder | Nigeria – Ghana – Kenya 90 MONDAY, OCTOBER 16

WORKSHOP

WS 16a T HE SUSTAINABLE DEVELOPMENT GOALS A n Opportunity to Accelerate Political Will SAAL 4 | AFRICA a n d Policy Coherence for Global Health World-Wide? 12:30 – 14:00

HOSTS

International Development Research Centre (IDRC)

M8 Alliance: The Graduate Institute of International and Development Studies

The SDGs do a remarkable job of illustrat- This makes sense in theory, but what is ing, for a global lay audience, how health the reality? What impact are the SDGs is both a product and a determinant of actually having on health on the ground? all other global public goods. As the de- Representatives of policy research institu- fining development compact of the next tions in Africa, Asia, South America, and 13 years, the SDGs thus provide a timely the South Pacific will describe the politi- and powerful window-of-opportunity for cal and governance dimensions of SDG health. Ideally, health stakeholders around roll-out in their countries, with an analysis the world should be empowered by the of what this means for health. This lunch- SDGs, to successfully demand greater time panel gives a taste of the contents political committment and cross-sectoral of a “Global Health Governance” journal policy coherence for health. special issue on these topics, which will be o²cally launched at the World Health Summit 2017 in Berlin. PROGRAM 91

CHAIRS

Zoe Boutilier Michaela Told International Development Research The Graduate Institute of International Centre (IDRC) | Program O²cer, and Development Studies | Global Health | Canada Executive Director, Global Health Centre | Switzerland Zoe Saadiya Boutilier Razzaq

SPEAKERS

Gonzalo Fanjul Saadiya Razzaq , MON 16 IS Global Barcelona | Sustainable Development Policy Institute Policy Director | Spain (SDPI) | Team Leader / Senior Research

Health SDGs and Europe: Associate | Pakistan GRAM O The role of Regional Think Tanks Accelerating SDG Implementation Gonzalo Michaela Fanjul Told PR in the South Asian Region Luiz Augusto Galvão Center for International Relations in Pablo Vega Health | Senior Researcher | Brazil National Health Fund (FONASA) | The 2030 Agenda and Chief of Cabinet | Chile Think Tanks in Latin America Political Engagement and Policy Coherence for Health-related SDGs Masuma Mamdani in Chile Ifakara Health Institute | Luiz Augusto Pablo Research Scientist | Tanzania Galvão Vega Health-related SDGs in Africa: the Case of Tanzania

Masuma Mamdani 92 MONDAY, OCTOBER 16

KEYNOTE

KEY 03 I NNOVATIONS SAAL 1 IN DIGITAL HEALTH RUDOLF VIRCHOW T ransforming Systems & Changing Lives 14:00 – 16:00

HOSTS

SAP SE

M8 Alliance: University of Coimbra

As the digital and genetics revolutions Like any tool, Digital Health is by itself converge with healthcare into the exciting neutral. It can either bring us closer to new field of Digital Health, we are increas- universal health care, or deepen the ingly able to track, manage, and improve divide between the rich and the destitute, both our own health and that of our loved the developed and the under-developed. ones. Digital Health is also helping to re - We need to understand how to steer duce ine²ciencies in healthcare delivery, Digital Health to ensure healthy lives while at the same time streamlining access, and promote well-being at all ages and improving quality and making medicine in all regions of the world. Advances more personalized and precise. are needed in issues like choosing which technologies should (and should not) The essential elements that are making be used by national health care systems the digital health revolution a reality in regions at di—erent levels of develop- include wireless devices, hardware and ment, on how to control complexity, and software sensing technologies, the keep costs under control. Internet, social networking, mobile and body area networks, health information Digital Health is probably the most im- systems, and genomic medicine. portant factor that will shape healthcare delivery in the years to come. PROGRAM 93

CHAIR

João Gabriel Silva Coimbra Hospital and University Centre (CHUC) | Dean & Acting President of the World Health Summit 2018 | Portugal Arnaud Thomas P. Bernaert Laur

SPEAKERS

Adalberto Campos Fernandes Carla Kriwet Ministry of Health | Minister | Portugal Royal Philips | Connected Care & Health , MON 16 Health Care Systems in Transition Informatics | CEO | and Digital Health United States of America

From Illegible to Immeasurable – GRAM Arnaud Bernaert O The Digitization of Healthcare Adalberto Elmar World Economic Forum | Global Health Campos Fernandes Nimmesgern PR and Healthcare Industries | Head | Thomas P. Laur Switzerland SAP SE | President of SAP Health | Why Would the Doctor Want United States of America to See You Now? Unleashing the Power of Digital: A Technologist’s View of Data-Driven Steven Hildemann Innovation in Healthcare Merck | Global Chief Medical O²cer,

Head of Global Medical A—airs and Elmar Nimmesgern Steven João Gabriel Patient Safety | Germany European Commission | Deputy Head Hildemann Silva Unlocking Tomorrow’s Cures – of Unit Innovative and Personalised Digitalization in the Pharmaceutical Medicine | Belgium Industry EU Action on Digital Transformation of Health and Care

Carla Kriwet 94 MONDAY, OCTOBER 16

PANEL DISCUSSION

PD 04b VA CCINATION APATHY Looking at The Non-rational Barriers SAAL 6 | EUROPE t o Health Protection Rational 14:00 – 16:00

HOSTS

M8 Alliance: London School of Hygiene & Tropical Medicine (LSHTM)

Pfizer Inc

Vaccination is an e—ective preventative Vaccine confidence does not solely apply healthcare measure to help protect against to those for whom vaccination is appro- infectious disease, and yet for many priate – research has shown that health- diseases and geographical areas, vaccina- care professionals too are a—ected by tion coverage rates are low. Despite the negative publicity around vaccination., historic success of immunization in re- With this in mind, the psychological drivers ducing the burden of illness and death, for, and barriers to adult vaccination for episodes of public concerns and rumours both healthcare professionals and the around vaccines have occurred around general public are assessed through the the world, spreading quickly and some- discipline of behavioural economics. times seriously eroding public confidence Consideration is given to how a range in immunization – ultimately leading to of stakeholders, including policy makers vaccine refusals and disease outbreaks. and the healthcare community, can take learnings form behavioural science to This panel discussion explores the state understand and address the emotional of vaccine confidence and adult vacci- barriers to adult vaccination, to help nation apathy, and its causes and influ- address the challenge of keeping our ences. The impact of vaccination apathy ageing population well in later life. is con sidered within the context of the globally ageing population, in light of the opportunity vaccination presents for healthy ageing. PROGRAM 95

CHAIR

Heidi J. Larson The Vaccine Confidence Project | Director | United Kingdom

Jane Pauline Barratt Paterson SPEAKERS

Jane Barratt Pauline Paterson International Federation on Ageing | London School of Hygiene & Tropical Secretary General | Canada Medicine (LSHTM) | Co-Director, , MON 16 Preventative Health: Vaccination The Vaccine Confidence Project | as a Tool for Healthy Ageing Co-Director | United Kingdom

Vaccination Apathy: GRAM Douglas E. Hough O The Role of the Healthcare Provider Douglas E. Horst Johns Hopkins Bloomberg School Hough von Bernuth PR of Public Health | Associate Scientist & Horst von Bernuth Associate Director, Master of Health Charité – Universitätsmedizin Berlin | Administration Program, Health Policy Head of Pediatric Immunology and and Management | United States Infectious Diseases | Germany of America The Impact of Infectious Disease Why do People Avoid Vaccines? in Later Life – The Need for a Lifelong A Perspective from Behavioural Approach to Vaccination Economics Heidi J. Larson 96 MONDAY, OCTOBER 16

PANEL DISCUSSION

PD 05 G L O BAL HEALT H SECURITY Policy Responses to Planetary Challenges SAAL 6 | EUROPE 16:30 – 18:00

HOSTS

Munich Security Conference (MSC)

Pfizer Inc

In recent years, global health security There is much work to be done in gaining has received increased attention. The universal acceptance of the global health Ebola outbreak brought attention to security agenda and improving collabo- the weaknesses in the systems of pre- ration between international, regional and paredness and response. In order to deal national actors. with these gaps a number of steps were taken. WHO has committed to improve However, health security involves more its emer gencies program, while private than just infectious disease outbreaks. ini tiatives have also been developed. Health security is also part of wider Regional organizations such as the EU health systems strengthening and Univer- and the African Union have increased sal Health Coverage activities, but it is their resolve to address global health not yet clear how to best synergise these security challenges. overlapping areas.

Yet despite these initiatives, the world Improving global health security is first is not ready for the next pandemic. and foremost a political endeavour. More Furthermore, some low-income countries commitment is required from beyond perceive the health security agenda as ministries of health; heads of state across a device for protecting the developed the globe must prioritise health as a world from health threats arising from political and security issue as well as a the under-developed world, thereby only medical one. advancing the interests of the West. PROGRAM 97

CHAIR

Wolfgang Ischinger Munich Security Conference (MSC) | Chairman | Germany

Peter Richard Albiez Hatchett SPEAKERS

Peter Albiez Richard Hatchett Pfizer Germany | CEO | Germany Coalition for Epidemic Preparedness Innovations (CEPI) | CEO | Lord Paul Boateng , MON 16 United Kingdom Parliament of the United Kingdom | Member of the House of Lords | Peter Salama GRAM

United Kingdom World Health Organization (WHO) | Lord Paul Wolfgang O

Executive Director, Health Emergencies Boateng Ischinger PR Laurie Garrett Programme | Switzerland Council on Foreign Relations | Senior Fellow for Global Health | United States of America

Laurie Peter Garrett Salama 98 MONDAY, OCTOBER 16

WORKSHOP

WS 17 G L O BAL HEALT H FINANCING New Tools for Promoting Accountability SAAL 10 | ASIA 16:30 – 18:00

HOST

SEEK Development, Strategic and Organizational Consultants GmbH

The objective of this session is to build in global health. The panel will also intro- an understanding about the critical duce participants to the Donor Tracker, importance of data transparency and a free online resource which provides accountability for global health, in par- quantitative and qualitative strategic ticular tools for tracking global health information on 14 major ODA donors. financing, policies and strategies. The For each donor, the Donor Tracker pro- speakers come from an academic, foun- vides data-driven insights on develop- dation, multilateral and NGO background. ment funding trends, strategic priorities, They will reflect on major topics that and decision-making processes. It also are critical for improving global health includes ‘Deep Dives’ on global health, and reaching SDG 3 (“Ensure healthy health R&D, agriculture and nutrition. lives and promote wellbeing for all at all ages”), including global health R&D, As such, the Donor Tracker is a highly health security, and financing for infec- relevant resource for advocates, re- tious diseases and reproductive, maternal, searchers, think tanks, policy-makers, newborn, child and adolescent health. journalists and academics working in the field of global health and develop- In their contributions, they will highlight ment. The speakers will present examples the role of new and emerging tools to of how they have used the Donor Tracker increase accountability and transparency to support their work and research. PROGRAM 99

CHAIR

Christina Schrade SEEK Development | Managing Director | Germany

Christoph Anja Benn Langenbucher SPEAKERS

Christoph Benn Kei Katsuno The Global Fund to Fight AIDS, Global Health Innovative Technology Tuberculosis and Malaria | Director of Fund (GHIT) | Investment Strategy & , MON 16 External Relations | Switzerland Development | Director | Japan Mobilizing Resources Advancing the Global Health to Finance Global Health R&D Pipeline GRAM Emanuele Maike O

Emanuele Capobianco Anja Langenbucher Capobianco Röttger PR The Partnership for Maternal, Newborn Bill & Melinda Gates Foundation | and Child Health | Deputy Executive Europe O²ce | Director | Director | Switzerland United Kingdom Promoting Accountability Investing in Global Health R&D for RMNCAH Maike Röttger Dean Jamison Plan International Germany | University of California, San Francisco | CEO | Germany Dean Christina Professor Emeritus | United States Evidence-based and Jamison Schrade of America Data-driven Advocacy Financing International Collective Action for Health

Kei Katsuno 100 MONDAY, OCTOBER 16

WORKSHOP

WS 18 WHY MUST PATIENT SAFETY

SAAL 2 | AMERICA S TART IN THE COMMUNITY? 16:30 – 18:00 Reducing Mortality from Sudden Cardiac Arrest and Maternal / Newborn Emergencies

HOSTS

European Resuscitation Council (ERC)

German Resuscitation Council (GRC)

M8 Alliance: National University of Singapore (NUS)

University Hospital of Cologne

Despite many e—orts to improve patient This is why joint e—orts gained increasing safety during the past years, morbidity importance for the improvement of and mortality rates are still alarmingly health in all humans – irrespective of their high. Maternal and children mortality are origin and age. Present low-threshold major health issues in the third world, and low-cost concepts such as school while sudden cardiac death is the third children education in cardiopulmonary leading cause of death in industrialised resuscitation found in the “Kids Save nations – and higher rates of bystander Lives” initiative should be implemented cardiopulmonary resuscitation increase in developing and developed countries, survival by factor 2–4. and safety for mothers and children need further support by politics, societies, and industry. PROGRAM 101

CHAIR

Bernd Walter Böttiger University of Cologne | Department of Anaesthesiology and Intensive Care | Director | Germany Lance B. Anita Becker Kale

SPEAKERS

Lance B. Becker Anita Kale

Northwell Health | Department of National University Hospital | , MON 16 Emergency Medicine | Chair | Women’s Centre | Division of Maternal United States of America Fetal Medicine | Consultant | Singapore GRAM

Cardiac Arrest and Resuscitation – Maternal Mortality in the World Bernd Walter Tore O

A Time to Act / I OM Statement Böttiger Lærdal PR Tore Lærdal Bernd Walter Böttiger Laerdal Medical Corporation | CEO | University of Cologne | Department Norway of Anaesthesiology and Intensive Care | Global Resuscitation Alliance, and its Director | Germany Relevance also to Low Medium Income Kids Save Lives – School Children Countries – including for Maternal / Education in CPR / Health and Newborn / Child Health Social Skills Hian Tat Ong Götz Hian Tat Bosse Ong Götz Bosse National University Hospital | Charité Universitätsmedizin Berlin | Division of Paediatric Neurology | Department of Anesthesiology and Head & Senior Consultant | Singapore Operative Intensive Care Medicine | Do’s and Dont’s for the Under Five Senior Physician | Germany Quality Management Programs to Reduce Maternal Mortality in the Third World 102 MONDAY, OCTOBER 16

WORKSHOP

WS 19 S EPSIS AND INFECTIONS ST SAAL 4 | AFRICA IN THE 21 CENTURY 16:30 – 18:00

HOST

Leibniz Association

At the beginning of the 21st century, severe infection that has spread into the book on infectious diseases is far the bloodstream, often resulting in organ from being closed. Increasing antibiotic failure. As well as constituting a life resistance, emergence of new pathogens, threatening condition, sepsis is one of together with changes in pathogen the most costly conditions regarding distribution due to altered climate and treatment, in 2011 more than 20 billion mobility and the rise in the undertaking dollars spent on fighting the disease in of invasive medical procedures present the US alone. Inconsistency in terms global challenges. This threat is further of recognition and assessment of symp- enhanced by a drastic lack of (new) toms continues to constitute a serious e—ective drugs as well as by insu²cient barrier to addressing the disease. preventive and diagnostic possibilities. This session focuses on the threats posed In particular, vulnerability to sepsis is by underestimated pathogens such as increasing on a global scale and is now human pathogenic fungi and multire- the third leading cause of death in the sistant bacteria as well as on strategies world. Sepsis refers to the life threatening to e—ectively diagnose and e²ciently condition in which the body fights a treat sepsis in its early stages. PROGRAM 103

CHAIR

Bernhard Hube Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (HKI) | Department of Microbial Pathogenicity Mechanisms | Vida Ulrich Hamilton Schaible Head | Germany

SPEAKERS , MON 16 Vida Hamilton Ulrich Schaible Health Services Executive | National Research Center Borstel – Leibniz-Center

Clinical Lead Sepsis | Ireland for Medicine and Biosciences | GRAM O The National Sepsis QI Programme Head of Cellular Microbiology | Germany Bernhard Markus Hube Weigand PR of Ireland The Global Challenge of Infections with Antibiotic Resistant Bacteria Oliver Kurzai such as Tuberculosis Julius Maximilians University of Wuerzburg | Medical Microbiology and Markus Weigand Mycology | Professor and Chair | German Sepsis Society | President | Germany Germany Challenges in Infection Control – Fulfilling the Goals of the Resolution Invasive Mycoses as a Case Study of the World Health Assembly Oliver Kurzai 104 MONDAY, OCTOBER 16

WORKSHOP

WS 20 PR OMOTING R&D CAPACITY

SAAL 5 | OCEANIA A ND MANUFACTURING 16:30 – 18:00

HOSTS

European and Developing Countries Clinical Trials Partnership (EDCTP)

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)

World Health Organization (WHO)

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH Organized by WHO/TDR and EDCTP, The panel session will start with an intro- the panel will critically reflect on current duction of the current state of capacity needs and gaps to enhance R&D capacity support for health research, followed by and manufacturing in low and middle a debate of panelists representing various income countries (LMIC). The panelists stakeholders and will conclude with an will explore several themes, including interaction with the audience. This session (1) various capacity support mechanisms; will generate interest from a diverse (2) harmonization through working with audiences attending the Summit, such as all partners and contribution of these funders and funding initiatives, health e—orts to SDGs 7, 9 and 17; (3) new research leaders, private sector, individual public-private partnerships models; researchers and policy makers at di—er- (4) need to assess and demonstrate ent levels. impact of the e—orts; and (5) co-funding and joint priority setting with LMIC. It is anticipated that the audience will equally contribute to the discussion and their input is expected to contribute to the summary recommendations that will guide all stakeholders for further action. PROGRAM 105

CHAIRS

Garry Aslanyan Ole F. Olesen World Health Organization (WHO) | The European & Developing Countries Special Programme for Research and Clinical Trials Partnership (EDCTP) | Training in Tropical Diseases (TDR) | Director | The Netherlands Manager of Partnerships and Garry Siaka Aslanyan Debe Governance | Switzerland

SPEAKERS , MON 16 Geo¼rey Banda Siaka Debe Innogen – Health and Innovation | National Center for Research and

Co-Director | United Kingdom Training on Malaria (CNRFP) | GRAM O The Link between Local Pharmaceutical Clinical Researcher | Burkina Faso Geo—rey Ole F. Banda Olesen PR Manufacturing and Local Health Systems Capacity Building in LMICs through Strengthening Innovative Fellowships

Detlef Böcking Jutta Reinhard-Rupp DLR Project Management Agency Merck KGaA, Darmstadt | Global Health on behalf of the Federal Ministry Institute | Head | Switzerland of Education and Research (BMBF) | The Pediatric Praziquantel Consortium: Global Health Research | Head | Germany A New Public-Private Partnership to Capacity Building in Sub-Saharan Africa Fill the Gap of an High Unmet Medical Detlef Jutta Böcking Reinhard-Rupp by Means of Networking, Mentorship Need in Young Children and Research Excellence 106 MONDAY, OCTOBER 16

SOCIAL EVENT

18:30 – 23:00 WOR LD HEALT H SUMMIT NIGHT

HOST

M8 Alliance

The World Health Summit Night is the Every participant of the World Health central social event with food, drinks and Summit is invited, external guests can entertainment. buy tickets on-site (ۮ40).

It hosts the award ceremony of the Startup Track, presented to the winner by German Minister of Health Hermann Gröhe. PROGRAM 107

SPEAKERS

Hermann Gröhe Detlev Ganten Bundesministerium für Gesundheit / World Health Summit | Federal Ministry of Health | President | Federal Minister | Germany Germany Hermann Detlev João Gabriel Silva Gröhe Ganten Hélène Boisjoly Coimbra Hospital and University University of Montreal | Centre (CHUC) | Faculty of Medicine | Dean & Acting President of the Dean & Acting President of the World Health Summit 2018 | , MON 16 World Health Summit 2017 | Portugal Canada GRAM

Hélène João Gabriel O

Boisjoly Silva PR 108 PROGRAM, TUESDAY, OCTOBER 17, 2017 109

PROGRAM

TUESDAY, OCTOBER 17 110 TUESDAY, OCTOBER 17

PANEL DISCUSSION

PD 06 T HE HEALT H IMPACT

SAAL 6 | EUROPE OF WAR & TERROR 9:00 – 10:30 Coordinating Aid

HOSTS

International Committee of the Red Cross (ICRC)

M8 Alliance: University of Montreal

The role of the public health community conflict by providing timely and credible in responding to the health impacts of information on the expected and actual war and conflict has become increasingly health consequences of conflict. The important in the context of the changing health community also has an important nature of war and conflict. While the role in preventing and treating injury global health community may have lim - and disease, as well as monitoring the ited power to curb the aggression and impact and the conduct of war within the belligerence of political and military legal framework set out by the Geneva leaders seeking out war and conflict, it Conventions and other instruments of can promote informed and open public international law. debate about the causes of war and PROGRAM 111

CHAIR

Hélène Boisjoly University of Montreal | Faculty of Medicine | Dean & Acting President of the World Health Summit 2017 | Canada Christine Tewodros Beerli Melesse

SPEAKERS

Christine Beerli Axel Radlach Pries International Comittee of the Red Cross Charité – Universitätsmedizin Berlin | (ICRC) | Vice-President | Switzerland Dean | Germany

Susanna Krüger Ahmad Tarakji Hélène Axel Radlach Save the Children Germany | CEO | Syrian American Medical Society | Boisjoly Pries Germany President | United States of America

Tewodros Melesse 17 International Planned Parenthood

Federation (IPPF) | Director General | , TUE United Kingdom GRAM O Susanna Ahmad Krüger Tarakji PR 112 TUESDAY, OCTOBER 17

WORKSHOP

WS 21 O NE HEALT H Life on Land & Life Below Water SAAL 10 | ASIA 9:00 – 10:30

HOSTS

Max Planck Society

Robert Koch Institute

The concept of One Health can be de- tion and the impact of the environment. fined as the collaborative e—ort of multiple Evolutionary Medicine provides such disciplines – working together locally, a framework by combining perspectives nationally and globally – to attain optimal from evolutionary biology, clinical medi- health for people, animals and the envi- cine and connected fields such as history. ronment. A comprehensive understanding of critical future challenges of human health The session will focus on key challenges on all levels needs such a holistic approach. for science, health policy and society deriving from the understanding that The elements – humans, animals, patho- individual and population health can only gens, nature in general and even tech nol- be maintained within healthy ecosystems. ogy and social aspects such as culture – The UN Sustainable Development Goals are interrelated. Biomedical technology acknowledge the relevance of the dynamic such as reproductive medicine, regene- interaction between humans, animals rative medicine and GWAS-based thera- and the environment which has major pies will heavily have a major impact on public health implications. human health in future. Understanding of both, natural and men-made evolution Humans and human health continue to of resistance genes and general pathogen change in future. To promote e.g. preci- adaptations provide critical knowledge sion medicine, one has to be aware of for future evidence-based medical inter- ongoing human evolution, global varia- ventions. PROGRAM 113

CHAIR

Bill S. Hansson Max Planck Society | Max Planck Institute for Chemical Ecology | Director | Germany Iain D. Paul Couzin Verschure

SPEAKERS

Iain D. Couzin Paul Verschure Max Planck Society | Max Planck Institute N-RAS Center for Autonomous System for Ornithology | Director | Germany and Neuro-Robotics | Director | Spain Social Contagion and Collective The Network Medicine of Brain Health: Decision Making in Animal Groups Linking Genotype, Phenotype and Environment in the Service of Wellbeing Bill S. Lothar H. Frank Rühli Hansson Wieler University of Zurich | Institute of Evolu- Lothar H. Wieler tionary Medicine, Faculty of Medicine | Robert Koch Institute | President | 17 Director | Switzerland Germany

Evolutionary Medicine: One Health at the Human-Wildlife , TUE Ongoing Evolution and Global Interface in Sub-Saharan Africa Perspectives on Human Health GRAM O Frank Rühli PR 114 TUESDAY, OCTOBER 17

WORKSHOP

WS 22 E QUITABLE ACCESS TO UNIVERSAL

SAAL 2 | AMERICA HEA LT H COVERAGE & CARE 9:00 – 10:30 Ensuring Social Participation

HOSTS

M8 Alliance: Tehran University of Medical Sciences

M8 Alliance: The Graduate Institute of International and Development Studies

Ensuring equitable access to universal patients voices in the setting of priorities. health coverage has many dimensions. The recognition of social participation is New models are emerging around the also reflected in the strong engagement world which ensure inclusiveness by of civil society in the new global Alliance strengthening social participation. These for UHC 2030. Strengthening account- include new mechanisms like people’s ability and advocacy are central to accel- health assemblies and other forms of erate progress towards universal health participation that ensure citizens and coverage. PROGRAM 115

CHAIRS

Ilona Kickbusch Amirhossein Takian The Graduate Institute of International Tehran University of Medical Sciences | and Development Studies | Global Health Department of Global Health and Policy | Center | Director | Switzerland Chair | Iran Danny Ophra Edwards Rebiere

SPEAKERS

Danny Edwards Ophra Rebiere Access to Medicine Foundation | Sanofi | Vice President, Head of Research Programme Manager | Corporate Social Responsibility | France The Netherlands The Private Sector Contribution Access to Medicines Index: in Ensuring Social Participation What Could the Private Sector do More Iraj Amirhossein Kevin Watkins Harirchi Takian Iraj Harirchi Save the Children UK | CEO | Ministry of Health and Medical United Kingdom 17 Education | Undersecretary | Iran UHC – How Does Civil Society Make

Expanding Access to Universal the Di¼erence in Achieving Equitable , TUE Health Coverage in Iran Progress

Dagnan N’Cho GRAM O Ministry of Health and the Fight against Ilona Kevin AIDS | Director General of Health | Kickbusch Watkins PR Ivory Coast UHC – The Critical Role of Communities and Community Health Workers

Dagnan N’Cho 116 TUESDAY, OCTOBER 17

WORKSHOP

WS 23 ANCIENT CU LT U RES,

SAAL 4 | AFRICA MGRA I TIONS AND HEALT H 9:00 – 10:30

HOST

Max Planck Society

Since the beginning of evolution, humans Recent genomic analyses support the and pathogens have been locked in a notion that the Y Pestis was the cause continuous arms race; health and disease of the Black Death pandemic and the were and continue to be directly linked Justinian Plague (Wagner et al. 2014, with cultural and population changes, Bos et al 2011). These findings enabled providing important possible lessons for historians to uncover the significance of dealing with today’s health challenges. Mediterranean, African and Asian com- Ten thousand years ago in the Early munications systems in explaining the Neo lithic period, the shift to a sedentary spread of diseases. The spread of patho- lifestyle, larger populations and domesti- gens has also been linked to intensified cated animals resulted in an increase trade and human mobility. The Roman of infectious diseases. Epidemics have communication system and the Chinese since then shaped human history, includ- Silk Road boosted world economic ing the colonization of the New World activity yet also facilitated the transmis- as well as the Black Death. sion of diseases. These findings shed new light on the possible impact and conse- The link between cultural and economic quences of modern migration in relation changes and the spread of pandemics to understanding and responding to has been a continuous source of debate. new health threats. PROGRAM 117

CHAIR

Johannes Krause Max Planck Institute for the Science of Human History | Director | Germany

Mark Angelika Achtman Messner SPEAKERS

Mark Achtman David Napier University of Warwick | University College London | Warwick Medical School | Professor Professor of Medical Anthropology | of Bacterial Population Genetics | United Kingdom United Kingdom The E¼ects of Migration on Immunity Typhoid Fever in 13th Century Norway Anne C. Stone Sebastien David Sebastien Calvignac-Spencer Arizona State University | Calvignac-Spencer Napier Robert Koch Institute | School of Human Evolution & Social Senior Researcher | Germany Change | Regents’ Professor | 17 Emerging Infectious Diseases from United States of America

non-Human Primates in Africa – Tuberculosis Epidemics in the , TUE One Past Health Approach (OPAH) pre-Columbian New World

Angelika Messner GRAM O Kiel University | Head of China Centre | Johannes Anne C. Germany Krause Stone PR The Evolution of the Idea of Chuanran 傳染 in China 118 TUESDAY, OCTOBER 17

WORKSHOP

WS 24 GROWING FROM RESPONSE

SAAL 5 | OCEANIA T OPR EPAREDNESS 9:00 – 10:30 Defining Priorities to address Global Health Threats

HOST

Foundation for Innovative New Diagnostics (FIND)

The recent back-to-back occurrence of ness for the inevitable next epidemic. two viral epidemics (Ebola and Zika) that CEPI·dx is a new global partnership blossomed into public health emergen- focused on diagnostics for health threats cies of international concern has high- prioritized by WHO. CEPIdx has been lighted the shortfalls of the global and initiated by CEPI and FIND to drive the local diagnostic response. Diagnostics are development and delivery of appropriate crucial in mitigating the e—ect of disease diagnostics and allow the rapid response outbreaks. As we come together to to future epidemics by strengthening develop the global health infrastructure diagnostic preparedness for a safer world. necessary to better face future infectious disease threats, the role of diagnostics This panel will allow participants to share must be considered foremost, and mecha- their experience and their points of view nisms established to carry out the logisti- on how the world can prepare to allow cal, financial, political, and technical work rapid response to future epidemics. required to ensure diagnostic prepared- PROGRAM 119

CHAIR

Catharina Boehme Foundation for Innovative New Diagnostics (FIND) | CEO | Switzerland

Arlene Nadia Chua Khelef SPEAKERS

Arlene Chua Nadia Khelef Médecins Sans Frontières | Institut Pasteur | MSF Diagnostic Working Group | Senior Advisor for Global A—airs | Leader | Switzerland France

Richard Hatchett Lars Schaade Coalition for Epidemic Preparedness Robert Koch Institute | Vice President | Catharina Lars Innovations (CEPI) | CEO | Germany Boehme Schaade United Kingdom Robert J. Stokes

Hans-Jochen Heinze Nielsen Tele Medical GmbH | CEO | 17 University of Magdeburg | Germany

Clinic of Neurology | Director | , TUE Germany GRAM O Richard Robert J. Hatchett Stokes PR

Hans-Jochen Heinze 120 TUESDAY, OCTOBER 17

KEYNOTE

KEY 04 VA CCINE RESEARCH SAAL 1 AND DEVELOPMENT RUDOLF VIRCHOW Challenges and Opportunities 11:00 – 12:30

HOSTS

Coalition for Epidemic Preparedness Innovations (CEPI)

M8 Alliance: London School of Hygiene & Tropical Medicine (LSHTM)

Max Planck Institute for Infection Biology

When it comes to fighting infectious ment are therefore a must, especially diseases, vaccines o—er top economic for neglected tropical diseases. A central and social value, and they also represent challenge is that in some developed the best means for controlling and countries, where popular perceptions eliminating dangerous communicable no longer view infection or epidemics pathogens. Intensified global e—orts to as a serious risk, mindsets will need step up vaccine research and develop- to change. PROGRAM 121

CHAIR

Peter Piot London School of Hygiene & Tropical Medicine (LSHTM) | Director & Professor of Global Health | United Kingdom Richard Heidi J. Hatchett Larson

SPEAKERS

Richard Hatchett Heidi J. Larson Coalition for Epidemic Preparedness The Vaccine Confidence Project | Innovations (CEPI) | CEO | Director | United Kingdom United Kingdom The Vaccine Confidence Project: Preventing Future Epidemics The Importance of Building Public Trust in Vaccines Stefan Peter Stefan Kaufmann Kaufmann Piot Max Planck Institute for Infection Biology‹‹| Director | Germany 17 TB Vaccine Candidate from the

Drawing Board to Clinical E´cacy Trial: , TUE An Example for a PPP between Germany and India GRAM O PR 122 TUESDAY, OCTOBER 17

PANEL DISCUSSION

PD 06a SHA PING THE FUTURE OF DIGITAL

SAAL 6 | EUROPE HEA LT H CARE IN THE DEVELOPI NG WORLD 11:00 – 12:30

HOST Deutsche Gesellschaft für Internationale Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) Zusammenarbeit (GIZ) GmbH

Digital technologies are on the way to However, the e—ective implementation transform access to health care tremen- of scalable digital health solutions face dously. Electronic patient records, new numerous challenges and lessons from medical data infrastructures to close practice show that currently not all current data gaps, mobile applications promises can be met. There is an increas- that support diagnostic and therapeutic ing need to harmonize technologies, practices, telemedicine that allows health allow interoperability between di—erent care over distances, or innovative logis- applications, or design public health tics infrastructures like the use of drones systems that can handle innovation. for the delivery of drugs to remote areas Yet, the pressure to find funds for new are just a few examples of how digital projects makes it di²cult to openly tools can be used for providing better debate failure and challenges. Leading health care. Without any doubt, the future international experts will discuss the of health is digital. The applications seem e—ects of the global digital transforma- to be infinite and they promise to be tion for health systems in the develop ing cost-e—ective, fast and easy to implement world. The aim of this session is to iden - while assuring high quality standards. tify the major chances and challenges in digital health and to formulate recommen- dations on how to design the future of digital global health. PROGRAM 123

CHAIRS

Norman Schräpel Juliane Zielonka Deutsche Gesellschaft für Health 2.0 Berlin | Co-Organizer | Internationale Zusammenarbeit (GIZ) | Germany Policy Advisor | Germany Michael Natalia Adelhardt Pshenichnaya

SPEAKERS

Salif Samake Nadi Kaonga Ministry of Health and Public Hygiene | citiesRISE | Technology Advisor | General Secretary | Mali United States of America Introductory Keynote Titus Kühne Michael Adelhardt Charité – Universitätsmedizin Berlin | Heidi Good Salif Deutsche Gesellschaft für Internationale Institute of Computer-Assisted Medicine | Boncana Samake Zusammenarbeit (GIZ) | Head of Section Director | Germany Health, Social Protection and Inclusion | Natalia Pshenichnaya 17 Germany GSMA | Head of mNutrition |

Heidi Good Boncana United Kingdom , TUE Global Digital Health Network |

Co-Chair | United States of America GRAM O Nadi Norman Kaonga Schräpel PR

Titus Juliane Kühne Zielonka 124 TUESDAY, OCTOBER 17

WORKSHOP

WS 24a B ETTER LEADERSHIP:

SAAL 4 | AFRICA IMPROVED HEALT H 12:30 – 14:00 Young Physician Leaders: “The Leadership We Want”

HOSTS

European School of Management and Technology (ESMT)

InterAcademy Partnership (IAP) for Health

Successful institutions need good leaders. here: www.iamp-online.org/iamp-young- And whether they are in high income physician-leaders-directory). In addition, countries or poorer countries, institutions a group of alumni were introduced to the providing healthcare, educating future 2016 World Health Assembly in Geneva. physicians or promoting the public’s health are no di—erent. Yet decision- IAP for Health YPL training events take makers in such institutions are often place immediately prior to the World appointed from among people trained Health Summit. This session will be in medicine, with little formal training designed by the 23 participants of the in leadership to prepare them for these 2017 event taking place on 12–14 October roles. The InterAcademy Partnership and will address challenges shared by (IAP) for Health Young Physician Leaders young physicians across low, middle (YPL) program aims to bridge this gap. and high income countries and solutions Launched in 2011, to date some 155 young that they see for making the changes physicians from some 45 countries have needed to improve health. participated in six international and one regional editions of this personalized The session is open to everyone – students, leadership training program (a dedicated young medical personnel at the start of IAP for Health YPL Directory is available their careers, as well as delegates holding more senior positions. PROGRAM 125

CHAIRS

Jo Ivey Bou¼ord Nora Ilona Grasseli InterAcademy Partnership (IAP) ESMT European School of Management for Health | YPL Program Leader | and Technology | Program Director | United States of America Germany Jo Ivey Nora Ilona Bou—ord Grasseli

SPEAKERS

Selected from among the 2017 Cohort of Young Physician Leaders 17 , TUE GRAM O PR 126 TUESDAY, OCTOBER 17

KEYNOTE

KEY 05 GOVE RNING THE FUTURE WITH THE SAAL 1 S USTAINABLE DEVELOPMENT GOALS RUDOLF VIRCHOW Followed by Closing Ceremony 14:00 – 16:00

HOST

M8 Alliance

The 2030 Agenda for Sustainable Devel- by the health sector acting alone – nearly opment aims to shape a very di—erent everyone of the SDGs can contribute world. The factors that now govern the to improving health and wellbeing. The well-being of the human condition, and SDGs also underline that governments the planet that sustains it, are no longer will need the support of many other so discrete. Health plays a central role in stakeholders to address the determinants this challenging agenda as a precondition, of health and priority health issues such outcome, and indicator of a sustainable as NCDs, UHC and poverty related society. The SDGs recognize that health diseases. challenges can no longer be addressed PROGRAM 127

CHAIR

Ilona Kickbusch The Graduate Institute of International and Development Studies | Global Health Center | Director | Switzerland Ilona Gerd Kickbusch Müller

SPEAKERS

Justin McCarthy Gerd Müller Pfizer Inc. | Global Policy and Federal Ministry for Economic Inter national Public A—airs | Cooperation and Development (BMZ) | Senior Vice President | Federal Minister | Germany United States of America How is Germany Contributing What Changes for the Private Sector? to the Implementation of the SDGs – Justin Elhadj As McCarthy Sy Does it live up to its Global Respon- At Home and Abroad? sibilities in the SDG Context? Elhadj As Sy Especially in Health? 17 International Federation of the Red Cross (IFRC) | Secretary General |

Matshidiso Rebecca Moeti , TUE World Health Organization (WHO) | Switzerland WHO Regional O²ce for Africa | Can the SDGs Really Help Address GRAM

Regional Director for Africa | Congo the Many Disasters and Emergencies O Matshidiso

How is WHO and WHO/Africa we are Facing? PR Rebecca Moeti in Particular Approaching the Intersectoral Approach to the SDGs? Will the WHO Work Di¼erently? 128 TUESDAY, OCTOBER 17

PANEL DISCUSSION

PD 06b ACCESS TO HEALT H Supply Chain & Delivery Systems: SAAL 6 | EUROPE Critical Enablers to Improving Access to Health 14:00 – 16:00

HOSTS

F. Ho¼mann-La Roche Ltd.

Merck

Novartis AG

The global health community is increas- approach that leverages the collective ingly focused on supply chain challenges‹– expertise and experiences of diverse as multi-lateral donors disburse grant stakeholders. Multi-stakeholder collabo- funding for commodity procurement, rations and public-private partnerships countries need to be prepared to e²- are becoming more and more instrumen- ciently absorb and utilize these funds for tal in addressing these key challenges maximum impact. Even when procure- and accelerating access to more a—ord- ment capacity is strong, last mile delivery able, safe and quality medicines. Equally challenges persist. The supply and de - important and often overlooked are the livery of health products and solutions upstream supply chain challenges where are among the key challenges to access limited collaboration among private that are often overlooked. Even the most sector companies can lead to ine²cient innovative and e—ective medicines can and more expensive delivery systems. be rendered useless if they are not safely and e—ectively delivered to the patients Recognizing these bottlenecks to e—ec- in need. tive supply chain and delivery systems, 13 private sector partners came together E—ectively addressing supply chain and in May 2014 to launch The Accessibility delivery challenges requires an inclusive Platform. A global health initiative, spear- PROGRAM 129

headed by the private sector, which This multi-stakeholder panel will provide aims at promoting information exchange, an overview of key challenges, identify best practice sharing and fostering potential areas for collective action and multi-stakeholder dialogue and collective highlight best practices to jointly address actions at the global, regional, and supply chain and delivery issues in a country levels. holistic manner to strengthen health H.E. Kwaku Philippe systems. Agyeman-Manu Francois

SPEAKERS

H.E. Kwaku Agyeman-Manu Philippe Francois Ministry of Health | Minister | Ghana Novartis AG | Vice President, Global Head of Supply Chain | Manfred Bruch Switzerland F. Ho—mann-La Roche Ltd. | Manfred Rüdiger First Mile Delivery Bruch Krech Head of Partner Collaborations | (Emerging Markets or Africa?) Switzerland

Last Mile / Capacity Building Rüdiger Krech 17 (Emerging Markets in General) World Health Organization (WHO) |

O²ce of the Assistant Director-General | , TUE Cristina Castro González de Vega Health Systems and Innovation | F. Ho—mann-La Roche Ltd. |

Director | Switzerland GRAM

Africa Strategy PT Program Lead | O Switzerland Cristina Castro Frédérique Frédérique Santerre PR González de Vega Santerre Last Mile / Capacity Building Merck | Global Head, Access to Health, (Africa SSA) Group Communi cations | Switzerland Awareness and Advocacy Martin Ellis The Global Fund to Fight AIDS, Tuberculosis and Malaria | Head of Supply Chain | Switzerland Sharing Supply Chain Best Practices and Partnership Collaboration Martin Ellis Experiences 130 TUESDAY, OCTOBER 17

PANEL DISCUSSION

PD 07 STR ENGTHENING INNOVATION

SAAL 6 | EUROPE A ND HEALT H SYSTEMS IN AFRICA 16:30 – 18:00 Achieving the Sustainable Development Goals

HOSTS

German Healthcare Partnership (GHP)

Joint United Nations Programme on HIV/AIDS (UNAIDS)

United Nations Member States have society, faith-based institutions and a shared commitment and a common private sector bodies in representing interest in achieving the Sustainable stakeholders while also delivering value Development Goals by 2030. Achieving and creating opportunities. this will require significant investment, innovation and partnerships in Africa. It This session will consider how distinct will benefit from integrated approaches goals, such as ending the AIDS epidemic to health, development and security, as in Africa, can not only be achieved well as consensus-building, information through integrated e—orts, but also how sharing and knowledge exchange. the tools and approaches can be used for social transformation and develop- The Panel Discussion will explore lessons ment and contribute to achieving other learned and opportunities arising from SDGs without leaving anyone behind. the aspirations of African Union’s Agenda 2063, the Third Industrial Development Speakers from communities, the private Decade for Africa, 2016–2025, and Ger- sector, science and politics will draw many’s experience as President of the on their experiences and strategies to G20, and in uniting diverse stakeholders explore opportunities and progress and the work of parliamentarians, civil in collaboration and innovation in Africa. PROGRAM 131

CHAIRS

Roland Göhde Luiz Loures German Healthcare Partnership (GHP) | The Joint United Nations Programme Chairman of the Board | Germany on HIV/AIDS (UNAIDS) | Deputy Executive Director | Switzerland H.E. Kwaku Luiz Agyeman-Manu Loures

SPEAKERS

H.E. Kwaku Agyeman-Manu Bakhuti Shengelia Ministry of Health | Minister | Ghana Novartis Foundation | Head, Global Health Portfolio | Switzerland Bernard S. Haufiku Ministry of Health and Social Services | Dazhu Yang Minister | Namibia International Atomic Energy Agency | Roland Bakhuti Deputy Director General | Austria Göhde Shengelia Chikwe Ihekweazu Nigeria Centre for Disease Control |

CEO and National Coordinator | Nigeria 17 , TUE GRAM O Bernard S. Dazhu Haufiku Yang PR

Chikwe Ihekweazu 132 TUESDAY, OCTOBER 17

WORKSHOP

WS 25 MAKING THE CASE FOR

SAAL 10 | ASIA O PEN CONTRACTING IN HEALT H 16:30 – 18:00 Tackling Corruption in Procurement

HOST

Transparency International

Healthcare and public procurement both and powerful case studies from Hon- su—er from high levels of corruption and duras, Ukraine and Nigeria that make the the point at which they converge, pro- case for open contracting in the health curement within healthcare, is an acute sector. vulnerability that is routinely exploited. But governments and civil society organi- Ensuring that funds are correctly invested sations are now taking action to protect has the potential to significantly improve the lives of citizens by implementing open service quality and health systems func- contracting. tioning, and can lead to better health outcomes overall. This is particularly In several countries, corruption has important to ensure that national health been significantly reduced throughout systems are robust enough to withstand the pro curement process following the major disease outbreaks. Come to this implementation of open contracting. workshop to learn how open contracting This workshop brings together 3 vibrant can help save lives. PROGRAM 133

CHAIR

Peter Eigen Transparency International | Founder and Chairman of the Advisory Council | Germany Peter Joseph Eigen Kraus

SPEAKERS

Abram Huyser-Honig Viktor Nestulia Association for a More Just Society | Transparency International Ukraine | Editor, Revistazo.com | Honduras Innovation Projects Programme | Opening Up Medicine Procurement Director | Ukraine in Honduras Everyone Sees Everything – Improving Healthcare Procurements Abram Viktor Joseph Kraus Huyser-Honig Nestulia in Ukraine The ONE Campaign | Transparency & Accountability | Director | 17 United States of America

The Value of Open Contracting , TUE for Nigeria’s Health Sector GRAM O PR 134 TUESDAY, OCTOBER 17

WORKSHOP

WS 26 A N T IMICROBIAL RESISTANCE Moving from Talk to Action SAAL 2 | AMERICA 16:30 – 18:00

HOST

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Anti-microbial resistance (AMR) renders management and surgery become high antibiotics ine—ective, via the reaction of risk procedures. The cost of healthcare micro-organisms when exposed to anti- rises for those a—ected by AMR due to microbial drugs. Misuse of antibiotics, longer duration of illnesses, additional poor infection control and inadequate tests and more expensive drugs. In 2014 sanitary conditions across the globe has approximately 480 000 people devel- encouraged the spread of AMR to the oped drug resistant TB, whilst in some detriment of both the economy as well countries treatment medication for E Coli as mortality rates, costing an annual is ine—ective in more than half the pa- estimated 1.5 billion Euros to the Euro- tients. This session focuses upon strate- pean Union healthcare system and gies to ensure both continued funding threatening the achievement of the SDGs. for medical research as well as e²cient production, availability and dissemination Without e—ective antimicrobials, standard of vaccines and other medicines to medical procedures such as organ trans- those who require them. plants, cancer chemotherapy, diabetes PROGRAM 135

MODERATOR

Astrid Frohlo¼ TV Moderator

SPEAKERS Thomas B. Jeremy Cueni Knox Thomas B. Cueni Jeremy Knox International Federation of Pharma- Wellcome Trust | Drug-Resistant ceutical Manufacturers & Associations Infections | Policy Lead | United Kingdom (IFPMA) | Director General | Switzerland Rüdiger Krech Karin Knufmann-Happe World Health Organization (WHO) | Federal Ministry of Health | Director O²ce of the Assistant Director-General |

General for Health Protection, Disease Health Systems and Innovation | Astrid Rüdiger Control and Biomedicine | Germany Director | Switzerland Frohlo— Krech 17 , TUE GRAM O Karin Knufmann-Happe PR 136 TUESDAY, OCTOBER 17

WORKSHOP

WS 27 HEA LT H Y EXCHANGE: HOSPITAL

SAAL 4 | AFRICA PARTNERSHIPS FOR GLOBAL HEALT H 16:30 – 18:00 A n Innovative Multistakeholder Approach t o Improve Quality and Access to Care

HOSTS

European ESTHER Alliance

German Federal Ministry for Economic Cooperation and Development (BMZ)

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)

Partnerships between universities and South and South-South collaboration Deutsche Gesellschaft hospitals of Southern and Northern between healthcare providers strenghten für Internationale Zusammenarbeit (GIZ) GmbH countries are a perfect example of the knowledge, access and networks on new generation of alliances between all sides and improve health systems governments, business and civil society and services alike. for a joint response to global health challenges including antimicrobial This session o—ers the opportunity to resistence, infectious and noncommu- members of the public sector both in nicable diseases. Northern and Southern countries, to representatives of the private industry Institutional health partnerships are and to the civil society to get to know collaborative platforms for professional each other, understand diverse moti- exchanges between peer clinicians and vations and explore how institutional o—er a new business model for private health partnerships may be the tool to companies from the health sector. The make innovation accessible in resource- benefits of these twinning arrangements poor settings and a mean to work are felt all round: institutional North- jointly for mutual benefit. PROGRAM 137

CHAIR

Brigitte Jordan-Harder ESTHER Germany | Senior Consultant and Health Specialist for Health Partnership Programs | Germany Klaus Farid Brill Lamara

SPEAKERS

Klaus Brill Farid Lamara Bayer AG | Corporate Commercial European ESTHER Alliance | Relations | Vice President | Germany Secretary General | France

Ibrahim Cunaku Augustin Sendegeya

VAMED Management und Service GmbH‹‹| University Teaching Hospital of Butare Ibrahim Augustin Deputy Head IT | Austria (CHUB) | Director | Rwanda Cunaku Sendegeya

Andrew Jones Heiko Warnken

Tropical Health and Education Trust German Ministry for Economic 17 (THET) | Head of Partnerships and Cooperation and Development (BMZ) |

ESTHER Alliance for Global Health Head of Division, Health, Population , TUE Partnerships | United Kingdom policy and Social Protection |

Germany GRAM O Andrew Heiko Jones Warnken PR

Brigitte Jordan-Harder 138 TUESDAY, OCTOBER 17

WORKSHOP

WS 28 EM ERGING TRENDS

SAAL 5 | OCEANIA I NP UBLIC HEALT H EDUCATION 16:30 – 18:00

HOSTS

M8 Alliance: Charité – Universitätsmedizin Berlin

M8 Alliance: London School of Hygiene & Tropical Medicine (LSHTM)

M8 Alliance: Monash University

M8 Alliance: Tehran University of Medical Sciences

Université Paris Descartes

M8 Alliance: Université Sorbonne Paris Cité

M8 Alliance: University of Geneva

Over the past several years, Public Health and innovative approaches to mobilising has been in the ascendancy as we have the future health workforce. realised the necessity of multiple ap- proaches to tackle the world’s major In this session, members of the M8 Alliance health problems and achieve the Sustain- will present recent developments in their able Development Goals. Coincidentally, educational endeavours in Public Health we have seen a revolution in educational which have been directed towards methods and exposure, with the advent enhancing engagement and innovation. of MOOCs, other forms of online learning PROGRAM 139

CHAIRS

Ben Canny Johanna Hanefeld University of Tasmania | London School of Hygiene & Tropical Faculty of Health | Head of Medicine | Medicine (LSHTM) | Associate Professor Australia Health Policy and Systems | United Kingdom Helen Rébecca Ackland Grojsman

SPEAKERS

Helen Ackland Rébecca Grojsman Monash University | Department of University of Geneva & Centre Virchow Epidemiology and Preventive Medicine | Villermé for Public Health | Senior Lecturer | Australia Scientific Collaborator | France Priorities in Teaching Refugee Nutrition and Climate Change Dina Johanna Balabanova Hanefeld and Asylum-seeker Health Education in MPH and Medical Curricula

Dina Balabanova Tobias Kurth 17 London School of Hygiene & Tropical Charité Universitätsmedizin Berlin | Medicine (LSHTM) | Department Institute of Public Health | , TUE of Global Health and Development | Director | Germany Associate Professor in Health Systems & Innovative Methodology as GRAM

Policy | United Kingdom a Prerequisite for Approaching O Ben Tobias

Strengthening Health Policy Emerging Global Health Issue PR Canny Kurth and System Research to Promote Amirhossein Takian Global Health Tehran University of Medical Sciences | Frédéric Dardel Department of Global Health and Policy | Paris Descartes University | Chair | Iran President | Frankreich Computer-based Simulation to Emerging Trends in Integrate SDH in Medical Students’ Public Health Education Curriculum Frédéric Amirhossein Dardel Takian

Genea r l Information

GENERAL INFORMATION 142 DIRECTIONS

HOW TO GET TO THE WORLD HEALTH SUMMIT

Kosmos Karl-Marx-Allee 131a 10243 Berlin Germany

U

U6 U U8 U U2 U Charité M10

U

U U

HAUPTBAHNHOF

U U U U ALEXANDER- U5 Kosmos PLATZ Berliner U Karl-Marx-Allee Dom U Unter den Linden U U2 U BRANDENBURGER Weberwiese U U TOR Frankfurter Tor

U U U U Gendarmen- markt U U M10 U Leipziger Straße OSTBAHNHOF

WARSCHAUER STR. U8 U U U

U U1 U6 U2

U U DIRECTIONS 143

From Tegel Airport (TXL) From Berlin, Hauptbahnhof (Mainstation) Take the bus line “TXL” to “Alexanderplatz” Take the train line “S7” in the direction of and change to the underground line “U5” in the “Ahrensfelde”, exit at “Alexanderplatz” and change direction of “Hönow”. Exit at the third stop at to the underground line “U5” in the direction of “Weberwiese”. The Kosmos will be 300 meter “Hönow”. Exit at the third stop at “Weberwiese”. down the road to the east. The Kosmos will be 300 meter down the road to the east. Duration: about 60 minutes Ticket: “Berlin Tarifgebiet A-B” (€ÆÆ2.80) Duration: about 20 minutes Ticket: “Berlin Tarifgebiet A-B” (€2.80)

From Schönefeld Airport (SXF) From Berlin, Alexanderplatz Take the train “RE7” in the direction of “Haupt- Take the underground line “U5” in the direction of bahnhof”, exit at “Alexanderplatz” and change “Hönow”. Exit at the third stop at “Weberwiese”. to the underground line “U5” in the direction of The Kosmos will be 300 meter down the road to “Hönow”. Exit at the third stop at “Weberwiese”. the east. The Kosmos will be 300 meter down the road Duration: about 10 minutes to the east. Ticket: “Berlin Tarifgebiet A-B” (€Æ2.80) Duration: about 40 minutes Ticket: “Berlin Tarifgebiet A-B-C” (€Æ3.40) By car If you arrive by car you can use the underground parking lot right at the venue.

Tegel Airport (TXL)

Berlin Hauptbahnhof ( ) Mainstation Berlin WelcomeCard The Berlin WelcomeCard enables free travelling with all public transport services, discounts of at least 25% and up to 50% at around 200 parti cipating partners, and a travel guide with various tour Schönefeld Airport (SXF) suggestions and insider tips. You can order your ticket at www.berlin-welcomecard.de/en 144 ACCOMODATION

Hotel Name Address Distance to Single Double venue Room Room

1 RAMADA Hotel Karl-Liebknecht-Str. 32 8 min (car) Berlin-Alexanderplatz Phone: +49 (0) 30 2389433 15 min (subway) €ÆÆ119.00 €ÆÆ129.00

2 Park Inn Alexanderplatz 7 7 min (car) by Radisson Berlin Phone: +49 (0) 30 3010411-0 12 min (subway) €ÆÆ109.75 €ÆÆ119.75

A 1.2 km B 1.6 km C 200 m D 15 min. 20 min. 2 min.

Alexanderplatz Strausberger Kosmos Frankfurter Tower Platz Tor Lounge

2.8 km 0.2 km U

U8 U2 U 2

A 1 U M10 Alexander- U platz U ALEXANDERPLATZ Schillingstr. B Kosmos U C Berliner Dom U Karl-Marx-Allee Strausberger D Platz U5 U U Weberwiese U U2 JANNOWITZBRÜCKE Frankfurter Tor

U U U8

M10 U U OSTBAHNHOF VENUE 145

SAAL 10 ASIA

Poster SAAL 7 Exhibition Startup ELIZABETH Track BLACKWELL

Speaker Center M8 SAAL 1 SAAL 6 Foyer Lounge RUDOLF VIRCHOW EUROPE Press Area

Karl-Marx-Allee OUTDOOR Meeting ROBERT KOCH Point SAAL 5 OCEANIA

SAAL 2 SAAL 4 AMERICA AFRICA 146 A–Z

ACCESS TO THE VENUE’ / ’SECURITY CURRENCY

To enter the World Health Summit venue parti- The currency used in Berlin is the Euro (€ or EUR). cipants are required to present a valid identity Automated teller machines (ATMs), are located card‹ / ‹passport or a similar personal identification everywhere in Berlin and they accept most main document (photo included). Please be advised credit cards such as Visa, Mastercard and that due to security reasons, all participants will be American Express. subject to a security check including a passport identification confirmation. We kindly ask you to EMERGENCY NUMBERS refrain from bringing your luggage to the venue, as this will slow down the security check process. Fire: 112 Ambulance: 112 AVAILABILITY Police: 110

Please note that the capacity of the venue and FILMING AND TAKING PICTURES of single session rooms is limited. If the maximum number of participants is reached, the organizers The organizer will provide a broad spectrum reserve the right to refuse access. of pictures and other graphical material for the representation of all World Health Summit events. CLOAKROOM These files will be made available at www.worldhealthsummit.org. The cloakroom is located on the left side of the venue and open during the whole event. HOMEPAGE

COFFEE BREAKS For up-to-date information regarding the World Health Summit, please visit Refreshments will be served during the co—ee www.worldhealthsummit.org. breaks. A–Z 147

INSURANCE AND LIABILITY MEDIA

The organizers cannot accept liability for per- Media representatives have access to all so nal injury, loss of or damage to belongings of o²cial sessions of the World Health Summit. participants, either during or as a result of the Prior accreditation is required via World Health Summit. Please check the validity www.worldhealthsummit.org/media/accreditation of your own insurance. Attendees are advised to arrange their own adequate travel and medical MOBILE PHONES insurance for medical treatment, accidents, cancellation of bookings etc. No responsibility As a courtesy to speakers and other attendees, will be accepted by the World Health Summit we kindly request that all mobile phones and organizers. similar devices will be turned to silent mode before entering a session. INTERNET’/’WIRELESS LAN NAME BADGE Complimentary Wi-Fi will be available within the venue: A badge is required for admittance to all World Name: WorldHealthSummit Health Summit sessions and events. Each parti- Password: #WHS2017 cipant is asked to present the badge in order to gain access to the venue. LANGUAGE PEOPLE WITH DISABILITIES The o²cial World Health Summit language is English. There will be no simultaneous translation. The venue is accessible to participants with disabilities. Please contact the Secretariat for LUNCHES assistance: Phone: +49 30 49855031 or [email protected] Lunches will be available during the lunch breaks. 148 A–Z

LOST AND FOUND POSTERS

Lost items can be collected at the registration A poster exhibition will be located at the poster desk during the World Health Summit. Any objects area in front of Saal 7 | Elizabeth Blackwell. found during the event and not claimed will remain at the venue. PUBLIC TRANSPORTATION

LIVE-STREAM’ / ’WEBCASTS Berlin’s public transport provides safe and com- fortable rides to almost all destinations in the city. All keynotes and panel discussions will be Tickets can be purchased directly at most train available as live-stream at stations and in all busses. www.worldhealthsummit.org More information: www.bvg.de Recorded webcasts will be available online after the event. REGISTRATION

PARKING The registration desk is open during the following times: An underground parking lot right at the venue is available. Sunday, October 15, 2017 08:00 – 22:00 Monday, October 16, 2017 08:00 – 22:00 PROGRAM CHANGES Tuesday, October 17, 2017 08:00 – 19:00

The organizers cannot assume liability for any SMOKING POLICY changes in the program due to external or un- foreseen circumstances. Please check the website It is forbidden to smoke in any part of the for regular updates. The organizers reserve the World Health Summit venue. right to cancel, postpone, relocate or change any of the sessions. A–Z 149

SPEAKER CENTER TAXIS

All speakers and presenters must report to the All o²cial taxis are colored o—-white with a yellow Speaker Center, located on the first floor, opposite taxi sign on the roof. The meter starts at a set of the entrance, at least two hours prior to their minimum price. presentation in order to check and upload their presentation. Please provide the data on a USB Major Taxi Hotlines: memory stick or a CD-ROM. Please note that you Taxi Berlin +49 30 202020 cannot run the presentation from your personal Taxi Würfelfunk +49 30 210101 laptop in the session room. Video support is at Taxi Funk +49 30 443322 the sole responsibility of the speaker. If there is no taxi available, please ask the The Speaker Center is open during the registration desk sta— for assistance. following times: TRAINING COURSE Sunday, October 15, 2017 08:00 – 18:00 Monday, October 16, 2017 08:00 – 18:00 Visiting physicians are accredited 6 points per day Tuesday, October 17, 2017 08:00 – 18:00 by the Berlin Chamber of Physicians. Please refer to the registration desk for further information. 150 CITY OF BERLIN

BERLIN – A METROPOLIS of Public Health in Baltimore. Other famous examples are the German Heart Centre – a FOR SCIENCE top-level hospital for heart and vascular diseases – or Germany’s largest hospital group Vivantes.

Medical care at the highest level requires a Berlin’s success as a health capital reflects a strong collaboration between scientists and 300-year tradition as a healthcare and scientific practitioners. Berlin is a leading centre of science centre. More than a dozen Nobel Prize winners and research in Europe, especially focusing on worked here, including researchers such as medicine. Four universities, the Charité teaching Rudolf Virchow and Robert Koch. One of Berlin’s hospital, seven universities of applied sciences most famous medical institutions is the renowned and over 30 private universities o—er teaching Charité, Europe’s largest university hospital and and research facilities for people from all over one of Germany’s leading hospitals. World- the world. Germany’s most important research renowned scientists of the Charité cooperate organizations such as the Fraunhofer-Gesellschaft closely with recognised research organisations or the Max Planck Society are based in Berlin such as the Johns Hopkins Bloomberg School and successful technology parks like the tech-hub Adlershof or biotech park Campus Berlin-Buch established here.

For more information This environment also makes Berlin a popular about Berlin as a meeting destination for international congresses in science destination, go to and medicine: twenty per cent of the approxi- convention.visitBerlin.com mately 64,000 meetings, conventions and events held in the first half of 2017 were in the fields of medicine, healthcare and pharmaceuticals. International conferences such as the World Health Summit show that the German capital has been able to consolidate its strong position as a destination for medical events. CITY OF BERLIN 151

BERLIN – CAPITAL OF CULTURE

Along with scientific conferences, Berlin also provides varied cultural experiences. From ancient art by the Old Masters to avant-garde design, from classical opera to musicals to pop concerts, Berlin’s cultural calendar leaves nothing to be desired. For all seasons, at all hours and for every taste, Berlin has something to o—er – 365 days large orchestras, including the world famous Berlin a year, 24 hours a day. Visitors to the capital can Philharmonic conducted by Sir Simon Rattle, choose from around 1,500 events a day. also make for high-class musical enjoyment.

Culture and art enthusiasts can also admire Among the cultural highlights this year is new styles and prominent works from all eras “The Luther E—ect. 500 Years of the Reformation”. every day in Berlin’s over 180 museums and To mark the 500th anniversary of the reformation approximately 440 galleries. The city’s best the Deutsches Historische Museum features an known museums include the five buildings at exhibition at the Martin-Gropius-Bau on the times Museum Island (Museumsinsel), which is in the of the reformation and the impacts of Protes- historic centre. All buildings display valuable tantism around the world until today. artistic treasures from 3,000 years of human history, e.g. the famous bust of Nefertiti in the Spectacular lighting design, extravagant costumes New Museum, while the New National Gallery and by designer Jean-Paul Gaultier, and a story that Martin-Gropius-Bau present contemporary art. gets under your skin: All that and more are on o—er in “The One Grand Show”, the most elaborate Berlin is the world’s only city to have three opera show in Europe. More than 100 dancers and houses: the Berlin State Opera (Berliner Staats- collages are used to create breath-taking scenes. oper), the Deutsche Oper and the Komische Oper. Classical music lovers can choose from a repertoire of famous works, such as Mozart’s For more events, visit Don Giovanni, or new and experimental operas. www.365-24.berlin Apart from these opera houses, the city’s eight 152 SPEAKER INDEX

A Bourdeaux, Margaret 85 Dietel, Manfred 67 Göhde, Roland 131 Achtman, Mark 117 Boutilier, Zoe 91 Dreifuss, Ruth 69 Goudou Co²e, Raymonde 45 Ackland, Helen 139 Boyle, Peter 67 Drosten, Christian 45 Grasseli, Nora Ilona 125 Adelhardt, Michael 123 Bricknell, Martin 85 Dworakowska, Anna 41 Gröhe, Hermann 73, 107 Agyeman-Manu, H.E. Brill, Klaus 137 Grojsman, Rébecca 139 Kwaku 131 Bruch, Manfred 129 E Albiez, Peter 97 Buckley, Marc 89 Eckardt, Kai-Uwe 51 H Alladi, Suvarna 71 Edwards, Danny 115 Habisch, André 89 Aslanyan, Garry 105 C Eggermont, Alexander 81 Hachinski, Vladimir 71 Aufmuth, Martin 89 Calvignac-Spencer, Eigen, Peter 133 Hacker, Jörg 55 Sebastien 117 Einhäupl, Karl Max 71 Haggenmiller, Christian 85 B Campos Fernandes, Ellis, Martin 129 Hamilton, Vida 103 Balabanova, Dina 139 Adalberto 93 Emmerling, Thea 59 Hanefeld, Johanna 65, 139 Banda, Geo—rey 105 Canny, Ben 139 Hansson, Bill S. 113 Baptista Leite, Ricardo 83 Capobianco, Emanuele 99 F Harirchi, Iraj 115 Bärnighausen, Till 45 Castro González de Vega, Fanjul, Gonzalo 91 Hatchett, Richard 97, 119, 121 Barratt, Jane 95 Cristina 129 Farmer, Jillann 85 Haufiku, Bernard S. 131 Baskozos, Giannis 65 Chan, Chang-Chuan 51 Fedorov, Maxim 77 Heinze, Hans-Jochen 119 Baumann, Michael 47, 81 Chen, Ya-mei 51 Flahault, Antoine 55 Hildemann, Steven 93 Baumann, Werner 73 Chua, Arlene 119 Francois, Philippe 129 Hirsch, Martin 57 Becker, Lance B. 101 Coles, Jan 43 Franz, Christoph 73 Ho—mann, Frank 89 Beck-Nielsen, Henning 81 Colombo, Francesca 77 Frohlo—, Astrid 135 Hörauf, Achim 79 Beerli, Christine 111 Coppel, Ross 77 Fukuhara, Shunichi 51 Hough, Douglas E. 95 Benn, Christoph 99 Couzin, Iain D. 113 Houllier, François 55 Bernaert, Arnaud 93 Cueni, Thomas B. 47, 135 G Hube, Bernhard 103 Blackburn, Elizabeth 49, 63 Cunaku, Ibrahim 137 Galea, Gauden 53 Huyser-Honig, Abram 133 Boateng, Lord Paul 97 Galvão, Luiz Augusto 91 Böcking, Detlef 105 D Ganten, Detlev 73, 107 I Boehme, Catharina 119 Dain, Katie 53 Garrett, Laurie 97 Ihekweazu, Chikwe 131 Boisjoly, Hélène 73, 107, 111 Dardel, Frédéric 139 Gerlach, Stefanie 83 Ischinger, Wolfgang 97 Boncana, Heidi Good 123 Deák, István 89 Germann, Stefan 57 Bonfiglioli, Elena 63 Debe, Siaka 105 Gerzer, Rupert 49 J Bosse, Götz 101 Delaney, David 77 Ghosh, Shiulie 47 Jack, Andrew 53 Böttiger, Bernd Walter 101 Depoux, Anneliese 55 Gitta, Brian 89 Jafarian, Ali 41 Böttinger, Erwin Paul 63 Dhatt, Roopa 43 Gless, Sabine 57 Jamison, Dean 87, 99 Bou—ord, Jo Ivey 125 Dierkes, Carsten 89 Godart, Patrick 85 Joanette, Yves 71 SPEAKER INDEX 153

Jones, Andrew 137 Lajeunesse, Yvette 51 Neidhardt, Harald 89 Röttger, Maike 99 Jordan-Harder, Brigitte 137 Lamara, Farid 137 Nestulia, Viktor 133 Rühli, Frank 113 Jordan, Neil 87 Langenbucher, Anja 99 Ngoma, Twalib 67 Larson, Heidi J. 95, 121 Nicotera, Pierlugi 81 S K Laur, Thomas P. 93 Nimmesgern, Elmar 49, 93 Salama, Peter 97 Kaindl, Arthur 57 Litman, Gilles 83 Nusser, Harald 45 Samake, Salif 123 Kale, Anita 101 Liu, Depei 49 Sanghvi, Bhaumik 89 Kaonga, Nadi 123 Liu, Joanne 73 O Santerre, Frédérique 129 Katsuno, Kei 99 Lohse, Martin J. 61, 63 Oduyebo, Olawunmi 43 Saso, Luciano 65 Kaufmann, Stefan 121 Loures, Luiz 131 Oelrich, Stefan 53 Schaade, Lars 119 Keller, Christian 89 Olesen, Ole F. 105 Schäfers, H.E. Reinhard 65 Khachaturian, Zaven 71 M Ong, Hian Tat 101 Schaible, Ulrich 103 Khelef, Nadia 119 Madelin, Robert 59 Schmitt-Lord, Thimo V. 88 Kibachio, Joseph 47, 53 Maduwage, Kalana P Schönweitz, Raphael 89 Kickbusch, Ilona 41, 115, 127 Prasad 89 Paikan, Feda Mohammad 85 Schrade, Christina 99 Klag, Michael J. 87 Mamdani, Masuma 91 Paterson, Pauline 95 Schräpel, Norman 123 Knieps, Franz 69 Matthews, Mary 89 Penk, Andreas 67 Schultze, Joachim L. 61 Knox, Jeremy 135 Mazigo, Humphrey D. 79 Piot, Peter 121 Schütte, Georg 87 Knufmann-Happe, Karin 135 McCarthy, Justin 127 Pries, Axel Radlach 111 Segurado, Aluisio Cotrim 79 Köhler, Carsten 79 McKee, Martin 59 Pshenichnaya, Natalia 123 Senaratne, Rajitha 53 Kornberg, Roger D. 73 Melesse, Tewodros 111 Sendegeya, Augustin 137 Kosch, Markus 67 Messner, Angelika 117 Q Seybold, Joachim 65 Kowalski, Corinne 55 Mired of Jordan, HRH Quinn, Laura 83 Shengelia, Bakhuti 131 Krause, Johannes 117 Princess Dina 47, 53 Shih, Chih-Yuan 51 Kraus, Joseph 133 Moeti, Matshidiso R Silva, João Gabriel 93, 107 Krech, Rüdiger 69, 129, 135 Rebecca 41, 127 Radbruch, Andreas 63 Singh, Sonia 43 Kriwet, Carla 93 Molyneux, David 79 Rajewsky, Nikolaus 61 Sipido, Karin R. 49 Krüger, Susanna 111 Moon, Suerie 69 Ralston, Johanna 83 Sowah, Mohammed Adjei 41 Kühne, Titus 123 Möröy, Tarik 63 Razzaq, Saadiya 91 Spiegel, Andrew 47 Kümmel, Björn 59 Mshinda, Hassan 57 Rebiere, Ophra 115 Spranger, Joachim 83 Kurth, Tobias 139 Müller, Gerd 127 Rees-Sidhu, Charlotte 43 Stier, Anna Babette 87 Kurzai, Oliver 103 Mundel, Trevor 45 Regateiro, Fernando 51 Stöckl, Heidi 65 Kuyumdzhieva, Albena 77 N Reinhard-Rupp, Jutta 79, 105 Stokes, Robert J. 119 L Nanyombi, Margaret 89 Ricciardi, Walter 65 Stone, Anne C. 117 Lærdal, Tore 101 Napier, David 117 Rocklöv, Joacim 55 Sullivan, Richard 85 Lahtinen, Eero 59 N’Cho, Dagnan 115 Rosling, Ola 77 Sy, Elhadj As 127 154 SPEAKER INDEX SUPPORTING INSTITUTIONS

T A Takian, Amirhossein 115, 139 Access Accelerated Tarakji, Ahmad 65, 111 B Theis, Fabian 61 Bayer Science & Education Foundation Theobald, Sally 43 Berlin Institute of Health (BIH) Thompson, Kelly 43 Bundeswehr Command and Sta— College Told, Michaela 91 C V Center for Global Health Engagement (CGHE) Vega, Pablo 91 Centre Virchow-Villermé for Public Health Paris-Berlin Verschure, Paul 113 Charité – Universitätsmedizin Berlin Vogel, Jörg 61 Coalition for Epidemic Preparedness Innovations (CEPI) Voigt, Wieland 81 D von Bernuth, Horst 95 Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) Vong, Sreytouch 43 Vyas, Akanksha 89 E European and Developing Countries Clinical Trials Partnership W (EDCTP) Warnken, Heiko 137 European Commission Wasunna, Monique 79 European ESTHER Alliance Watkins, Kevin 115 European Resuscitation Council (ERC) Weber-Mosdorf, Susanne 69 European School of Management and Technology (ESMT) Weigand, Markus 103 F Wieczorek-Zeul, Heidemarie 43 F. Ho—mann-La Roche Ltd. Wieler, Lothar H. 45, 113 Fondation Botnar Wiestler, Otmar D. 49 Foundation for Innovative New Diagnostics (FIND) Wuliji, Tana 43 G Y German Association of Research-based Pharmaceutical Yang, Dazhu 131 Companies (VFA) German Centers for Health Research (DZG) Z German Federal Ministry for Economic Cooperation Zaman, Muhammad H. 55 and Development (BMZ) Zielonka, Juliane 123 German Healthcare Partnership (GHP) Zuniga, José 41 German National Academy of Sciences Leopoldina e.‹V. German Network against Neglected Tropical Diseases (DNTDs) German Resuscitation Council (GRC) SUPPORTING INSTITUTIONS 155

H P Harvard Medical School Pfizer Inc Heidelberg Institute of Public Health (HIPH) R Helmholtz Association of German Research Centers e.‹V. Robert Koch Institute I S Institut de Recherches Cliniques de Montréal (IRCM) Sanofi InterAcademy Partnership (IAP) for Health SAP SE International Committee of the Red Cross (ICRC) Sapienza University International Development Research Centre (IDRC) Scientific Panel for Health (SPH) International Federation of Pharmaceutical Manufacturers & SEEK Development, Strategic and Organizational Associations (IFPMA) Consultants GmbH J T Johns Hopkins Bloomberg School of Public Health Tehran University of Medical Sciences Joint United Nations Programme on HIV/AIDS (UNAIDS) The Graduate Institute of International and K Development Studies King’s College London The NCD Alliance Kyoto University Transparency International

L U Leibniz Association Université Paris Descartes London School of Hygiene and Tropical Medicine (LSHTM) Université Sorbonne Paris Cité University Hospital of Cologne M University of Coimbra M8 Alliance University of Geneva Max Delbrück Center for Molecular Medicine (MDC) University of Montreal Max Planck Institute for Infection Biology Max Planck Society W Merck Women in Global Health Monash University World Dementia Council (WDC) Munich Security Conference (MSC) World Health Organization (WHO) World Stroke Organization (WSO) N National Taiwan University (NTU) National University of Singapore (NUS) Novartis AG 156 PARTNERS

SPONSORING PARTNERS

Strategic Partners Major Partners

Gerneral Partners PARTNERS 157

SUPPORTING PARTNERS

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH

Printing Partner:

NIELSEN TELE MEDICAL Data for Good

SERVICE PARTNERS

Concept Partner: Mobility Partner: 158 PARTNERS

POLICY MAKERS

ACADEMIA

PARTNERS 159

CIVIL SOCIETY

T

H E E M C O L R UB OF 160 PARTNERS

ASSOCIATES

Digital Health

MEDIA PARTNERS

In Zusammenarbeit mit:

Polish Healthcare Journal

Ogólnopolski System Ochrony Zdrowia MEDIA INFORMATION 161

Media Registrations Media Access Media Registrations are available free of charge Media has access to all o²cial sessions of the to journalists (pending proof of a²liation). World Health Summit. Prior to the World Health Summit, please apply for your registration online via Press Area www.worldhealthsummit.org/media/accreditation First floor, opposite of the venue entrance

During the event, please contact the media The press area can be used during the whole accreditation counter at the registration desk. World Health Summit.

PRESS CONTACT Tobias Gerber & Daniela Levy [email protected] [email protected] Tel.: +49 30 450 572 114

PRESS CONFERENCE Sunday, October 15, 15:00–15:45 Saal 7 | Elizabeth Blackwell 162 CONTACTS

WHS Foundation GmbH Strategic Communications Director c/o Charité – Daniela Levy Universitätsmedizin Berlin [email protected] Charitéplatz 1 Tel.: +49 30 450 572 114 10117 Berlin, Germany Fax: +49 30 450 517 911

World Health Summit PA to the Founding President Presidents Pascale Schulte Hélène Boisjoly [email protected] Detlev Ganten Tel.: +49 30 450 572 102 Fax: +49 30 450 517 911 Managing Directors Jörg Heldmann PA to the Managing Director [email protected] Petra Neitzel Tel.: +49 30 450 572 118 [email protected] Fax: +49 30 450 517 911 Tel: +49 30 450 572 219 Fax: +49 30 450 517 911 Alexander Hewer Organizing Secretariat Program Director Agentur WOK GmbH Julian Kickbusch Palisadenstraße 48 [email protected] 10243 Berlin, Germany Tel.: +49 30 450 572 122 Fax: +49 30 450 517 911 Project Manager Nicole Rudolph Press & Public Relations Director Registration Department Tobias Gerber Felix Heller, Kristin Keller [email protected] Tel.: +49 30 450 572 114 Fax: +49 30 450 517 911 www.worldhealthsummit.org 163 164 165 166 IMPRINT

Photo Credits Angela Merkel, Page 8¦© Bundesregierung | S. Kugler Potsdamer Platz, Berlin, Page 11¦© iStockphoto | andrearoad Karl Max Einhäupl, Axel Radlach Pries, Astrid Lurati, Ulrich Frei, Page 14 & 15¦© Charité‹–‹Universitätsmedizin Berlin Rolf Zettl, Page 15¦© David Ausserhofer | Helmholtz Martin Lohse, Page 15¦© Bettina Flitner | MDC Bärbel-Maria Kurth, Page 21¦© Robert Koch Institute | Dugnus Eckart von Hirschhausen, Page 22¦© Frank Eidel Otmar D. Wiestler, Page 49¦© DKFZ Kosmos, Page 19, 145¦© Kosmos KG Hermann Gröhe, Page 32, 73, 107¦© Jochen Zick (action press) Peter Albiez, Page 97¦© Pfizer Deutschland GmbH Panorama Berlin, Page 150¦© visitBerlin | Wolfgang Scholvien Konzerthaus Berlin, Page 151¦© visitBerlin | Gutscherra / Ostho—

Layout Eta Friedrich, Berlin

Printer Laserline, Berlin W orld Health Summit

WHS Foundation GmbH c / o Charité – Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany

Tel.: +49 30 450 572102 Fax: +49 30 450 572911

[email protected] www.worldhealthsummit.org SA VE THE DATES

WORLD HEALTH SUMMIT REGIONAL MEETING

COIMBRA, PORTUGAL APRIL 19–20, 2018

WORLD HEALTH SUMMIT

BER LIN, GERMANY OCTOBE R 14–16, 2018

www.worldhealthsummit.org